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Abstract 
Lewis antigens constitute a family of fucosylated carbohydrate antigens (glycotopes), 
involved in leukocyte homing and related immunological phenomena. These glycotopes 
are only expressed restrictedly in normal cells, but are induced at appropriate occasions. 
It is well established that many tumors “hijack” Lewis glycotopes for e.g. extravasation 
and metastasis, and recent data indicate that also human retroviruses may use a similar 
strategy for colonization of distal tissues. The overall goal of the present thesis was to 
explore the prerequisite for this phenomenon to occur in cells infected with 
herpesviruses, a virus family where persistent infections and immune evasion are 
important hallmarks.  
Using confocal immunofluorescence, neo-expression of Lewis antigens was found on 
cells infected with herpes simplex virus type-1 (HSV-1), varicella-zoster virus (VZV), and 
cytomegalovirus (CMV). However, whereas the neurotropic viruses VZV and HSV-1 
induced sialyl Lewis x (sLex), CMV induced Lewis y (Ley) at the surface of the infected 
cells. Real time RT-PCR methods for transcriptional analysis of all known human 
fucosyltransferase genes (FUT) were developed to determine the mechanism behind 
virus-specific induction of different glycotopes. The herpesviruses investigated were all 
able to induce transcription of FUT3, FUT5 and FUT6 relevant for sLex and Ley synthesis 
whereas only CMV induced FUT1, necessary for Ley expression. In most cases the 
transcriptional activity of these genes was several orders of magnitude larger in virus-
infected cells compared to uninfected cells.  
The viral factors causing neo-expression of glycotopes were explored using FUT5 and 
the HSV-1 infected cell as a model system. It was found that the transcripts of the 
immediate early viral gene, designated ICP0, was able to induce FUT5 transcription 
without assistance of the translated gene product. This finding explained the extremely 
early occurrence of host FUT5 RNA, detectable as early as one hour post infection. 
However, several other viral factors were engaged in regulation of the FUT5 
transcription downstream the ICP0 induction. The viral glycoprotein gC-1 was identified 
as a probable candidate as a carrier of O-linked glycans and important regulatory 
elements of the O-glycosylation sequon of gC-1 were characterized. These regulatory 
elements were decisive for the social behavior of virus-infected cells in culture.  
The conclusion of the present work is that herpesviruses possess powerful mechanisms 
for viral control of the expression of selectin ligands and similar glycotopes, of relevance 
for tumor metastasizing and tissue invasion of human transforming retroviruses. sLex 
and Ley constitute targets for development of cancer chemotherapy, but further 
investigation is necessary to determine whether this approach is applicable also for 
treatment of herpesvirus-infections.  
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List of Abbreviations and Acronyms 
CHX Cycloheximide 
CMV Cytomegalovirus 
CS Chondroitin sulfate 
DC Dendritic cell 
DC-SIGN Dendritic cell-specific ICAM-3-grabbing nonintegrin 
dl1403 HSV-1 mutant with deletion in ICP0 
E Early 
FITC Fluorescein Iso-thiocyanate 
Fuc fucose 
Fuc-TI fucosyltransferase 1 
FUT Fucosyltransferase gene 
Gal galactose 
GalNAc N-acetyl galactosamine 
gC, gD glycoprotein C, D 
GlcNAc N-acetylglucosamine 
Glycotope Acronym for carbohydrate epitopes, defined by a specific antibody or lectin 
GMK Green monkey kidney cells 
HEL Human embryonic lung fibroblasts 
HS Heparan sulfate 
HSV-1 Herpes simplex virus type-1 
HSV114,117 HSV-1 mutated at gC aminoacid 114 and 117 
HTLV-1 Human T-cell leukemia virus type-1 
ICP0 Infected cell protein 0 
IE immediate early 
L Late 
LAT Latency associated transcript 
Lea Lewis a 
Leb Lewis b 
Lex Lewis x 
Ley Lewis y 
MOI Multiplicity of infection 
ND10 Nuclear domain 10 
PCR Polymerase chain reaction 
pgC Precursor gC 
sLea sialyl Lewis a 
sLex sialyl Lewis x 
TRITC Tetramethyl Rhodamine Iso-Thiocyanate  
tsS HSV-1 temperature sensitive mutant in ori binding protein 
tsK HSV-1 temperature sensitive mutant in ICP4 
VHS Virion host shut-off 
VZV Varicella-zoster virus 
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Introduction 
Lewis antigens, carbohydrates closely related to the ABO histo-blood group antigens, are 
important ligands for selectins, whose interactions are of relevance for leukocyte 
homing. Selectin binding of leukocytes via sialyl Lewis x (sLex) and related antigens 
allow cells to bind weakly to the epithelial cells, forcing the leukocytes to roll along the 
blood vessel, resulting in tighter bindings and eventually passing of the leukocyte across 
the epithelial barrier. The powerful leukocyte homing mechanism, offered by selectin 
interactions with their ligands, has been hijacked by different types of tumors during 
metastasis. This allows the circulating tumor cells to pass through the blood vessel wall. 
In addition to sLex, a related carbohydrate structure, Ley, has also been implicated in 
tumor progression. Ley was for a long period of time believed to be expressed only on 
tumor cells, but recently Ley has been shown to be expressed in very high amounts in 
sperm and seminal fluids, where the most prominent hypothesis includes a role for Ley 
in immune suppression. Tumor cell expression of Lewis antigens has been described in 
detail and antibodies against these antigens are under investigation at various 
pharmaceutical companies. 
Virus-infected leukocytes, or cells that are detached by virus infection, may circulate in a 
manner similar to that described above for metastasizing tumor cells. In analogy, 
expression of selectin ligands, e.g. O-linked glycans, on cells would provide such viruses 
with an excellent mechanism for colonization of distal tissue. This appears as a 
particularly advantageous strategy for representatives of the families Retroviridae and 
Herpesviridae, owing to their long-lasting relationship with their hosts, including latent 
or persistent infection. Indeed, the significance of virus-induced sLex and its interactions 
with selectin has been proven for the pathogenesis of HTLV-1-induced lymphoma in 
humans. In spite of the potential relevance of selectin interactions for herpesvirus 
pathogenesis, not least in immunocompromised patients, we know little regarding to 
what extent herpesviruses express selectin ligands and essentially nothing regarding the 
strategies by which herpesviruses may induce such carbohydrates in the infected cells. It 
is however intriguing that essentially all human herpesviruses specify at least one 
glycoprotein that is tailor-made to present numerous O-linked glycans at the infected 
cell surface, including Lewis antigens, provided that the other requirements for 
synthesis of such glycotopes are fulfilled in the infected cell. 
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Aims of the present thesis 
The overall aim of this thesis is to determine the ability of different herpesviruses to 
introduce Lewis antigens and related biologically active carbohydrate epitopes in 
infected cells and to identify the underlying mechanisms behind this phenomenon, with 
respect to viral and host factors involved. The specific aims are: 
I. To demonstrate possible neoexpression of such carbohydrates and determine whether 
different herpesviruses induce different carbohydrate epitopes. 
II. To examine the functionality of a putative signal sequence of a herpesvirus model 
glycoprotein regarding its ability to participate in the early steps in formation of such 
carbohydrates. 
III. To develop a method for measuring the transcription rates of host genes, encoding 
the fucosyltransferases necessary for synthesis of relevant Lewis antigens. 
IV. To characterize possible virus-induced changes in the transcription rates of these 
genes in herpesvirus-infected cells for identification of the host factors responsible for 
altered glycosylation. 
V. To identify the viral factors responsible for altered glycosylation and to determine the 
viral mechanism behind the induction of specific Lewis antigens. 
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Herpesviridae 
The herpesviruses, herpesviridae, are enveloped DNA viruses containing a large linear 
genome ranging between 100 and 240 kb in size.  The viral DNA is enclosed in a 100nm 
large capsid, surrounded by a tegument consisting of viral and cellular proteins and 
RNAs important for viral gene transcription, see Fig 1 (73). All herpesviruses share a 
similar gene expression pattern with 40 open reading frames (ORFs), conserved among 
all the known herpesviruses (reviewed in (50)). When these genes are expressed, the 
herpesvirus infected cell enters a lytic phase and virions are released from the cell. 
Herpesviruses are also able to cause latent infection of various celltypes, where the 
circular viral DNA resides in the infected cell nucleus. Latency may involve expression of 
some viral genes, though progeny virions are not formed (73). Latency may, due to 
different factors, induce reactivation where the virus is able to enter the lytic phase of 
infection. 
The herpesviridae are divided into three subgroups: α, β and γ. Herpesviruses in general 
cause subclinical infections, however, they may cause recurrent infections and are 
especially critical for immunocompromised individuals, resulting in life-threatening 
disease. α herpesviruses, herpes simplex type 1 and 2 (HSV-1 and -2) and varicella-
zoster virus (VZV), latently infect neurons during primary infection. HSV-1 and HSV-2 
may reactivate, causing oral and genital lesions respectively, but may also cause 
encephalitis or keratoconjunctivitis. VZV, unlike HSV, spreads through the respiratory 
route primarily infecting the mucous membrane of the lungs, where the virus is spread 
to regional lymph nodes infecting tonsillary memory T-cells. Infected T-cells transport 
the virus to the skin, finally causing skin lesion in the form of chickenpox in children or 
zoster during adult reactivation (39, 59). β herpes viruses, i.e. cytomegalovirus (CMV) 
infects white blood cells usually causing subclinical infection, although CMV causes 
severe infections in immunocompromised patients, i.e. transplantation patients and 
AIDS patients. γ herpes viruses, e.g. Epstein-Barr virus, inducing proliferation of B-
lymphocytes causing mononucleosis.  
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Fig 1. HSV animated structure including gC-1 detailed structure. Diamond shaped sticks 
represents N-linked glycans and the black box represents a peptide stretch, containing 
clustered O-linked glycans. 
 
Viral Replication 
A summarized description of the viral replication with emphasis on the steps relevant 
for this thesis is given below. For brevity, only HSV-1 is reviewed since all herpesviruses 
utilize the same replication strategy. The HSV-1 envelope contains as many as 11 
different glycoproteins (g), of which gB, gC and gD are essential for the early steps in 
cellular infection. Initial binding of HSV-1 to the primary cellular receptors, 
glucosaminoglycans, via gC and gB is followed by fusion of the viral and cellular 
membranes. The viral capsid utilizes the nuclear pore complex to release the viral DNA 
and tegument proteins into the nucleus. The infected cell enters the lytic or latent 
pathway, depending on whether viral gene expression is engaged or not. During latent 
infection the viral genome is circularized and LAT (latency-associated transcripts) are 
the only transcripts detected in latently infected neurons (4). Latent infection can be 
reactivated, at which point the immediate early (IE) genes are transcribed. During the 
lytic infection, expression of IE genes induces early (E) and late (L) gene expression. 
Expression of the E genes allows replication of the viral DNA and the L, structural, genes. 
Virion particles are then formed and released from the cell (73). 
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Transcription of viral and cellular genes in the HSV-1-infected cell 
The transcription program of the viral genome is initiated by the tegument protein VP16 
along with cellular transcription factor Oct-1 and HCF, which together are responsible 
for induction of viral gene ICP0 (infected cell protein 0) by binding to the ICP0 promoter 
(15, 22). The VP16, Oct-1 and HCF complex also activates ICP4 transcription. ICP0 and 
ICP4 function together as crucial viral proteins for transcription of the other IE genes, 
ICP22, ICP27 and ICP47, and thereby initiation of transcription of all viral genes, though 
only ICP4 is essential for viral replication (15). ICP0 deletion mutants are able to 
replicate, however, low MOI results in a much slower lytic cycle (7). Several of the IE 
genes are also involved in regulation of cellular genes. ICP0 is not able to bind DNA, but 
activates many cellular genes, though no specific promoter has been described 
(Reviewed in (15)). IE protein ICP22 activates RNA polymerase II, essential for gene 
transcription (62), ICP27 also interacts with RNA polymerase II as well as promoting 
transportation of viral, single exon, RNA to the cytoplasm from the nucleus (11) and 
effects cellular RNA stability in association with tegument protein VHS (virion host shut-
off) (56).  
Viral transcription radically effects cellular gene transcription by altering mRNA 
processing. Cellular genes redundant to the herpesvirus are shut down by VHS 
degrading preexisting and newly transcribed cellular mRNA, and ICP27 blocks cellular 
pre-mRNA splicing, both playing a role in reducing cellular mRNA levels in the infected 
cell. Contrary to the paradigm that all cellular genes are shut-off, many studies indicate a 
much more fine-tuned regulation, where genes coding for transcription factors and/or 
genes involved in transcriptional regulation are up-regulated early in the infection. 
Genes involved in oncogenesis, stress-response and cell-cycle regulation have also been 
found to be up-regulated (70).  
The IE genes induce transcription of the delayed early genes, DNA polymerase, DNA 
binding proteins, ORI binding protein and helicase/primase complex, all being essential 
for viral infection. Expression of the DE genes is followed by expression of the late and 
the true late genes, mainly coding for structural as well as viral DNA replication genes 
(74).  
 
Glycoprotein C and glycosylation of viral glycoproteins 
All human viruses rely on the host cell glycosylation machinery, implying that the 
resulting glycans are host specific (54). The specificity of a given oligosaccharide 
depends on the specific set-up of glycosyltransferases in a cell at a given time. 
Glycosyltransferases catalyze the addition of one monosaccharide to the growing 
oligosaccharide chain. The added monosaccharide is linked via its carbon atom to one of 
the free hydroxyl groups of an accepting monosaccharide. The structural information of 
the oligosaccharide is determined via the three levels of specificity of a 
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glycosyltransferase: Specificity for (i) the identity of the monosaccharide to be donated, 
(ii) the structure of the oligosaccharide acceptor and (iii) the glycosidic linkage to be 
generated (α or β anomery for the donated monosaccharide and up to four free 
hydroxyls available at the accepting monosaccharide) (23, 75, 79). This implies there is a 
huge number of different human glycosyltransferases (35) because although the number 
of the most frequent monosaccharides is less than ten, the number of possible acceptor 
glycan structures and possible linkage types is very large. The glycans of glycoproteins 
are classified according to the type of linkage between the innermost monosaccharide 
and the amino acid of the glycoprotein. Viral envelope glycoproteins contain two types 
of glycans, i.e. N-linked glycans where a GalNAc is attached to the amide nitrogen of Asn 
or the O-linked glycans that are linked to the hydroxyl group of Thr or Ser. 
N-linked glycosylation is initiated by transfer of a pre-built, large, mannose-rich, glycan 
precursor from a lipid to Asn of the glycoprotein (Reviewed in(42)). The peptide signal 
essential for glycan acceptance is relatively well defined, N-X-S/T where X cannot be a 
proline. After addition of the mannose-rich precursor the N-linked glycans is processed 
further by glycosidases and glycosyltransferases to rather large and branched glycans. 
N-linked glycosylation will not be discussed in detail, as they are not studied in the 
present work.  
O-linked glycosylation is sometimes referred to as mucin-like glycosylation if numerous 
O-linked glycans are tightly clustered on specific peptide stretches of the glycoprotein, 
which is the case for gC-1 and a number of other herpesvirus glycoproteins. Usually O-
linked glycans consist of shorter chains than the N-linked glycans although there are 
exceptions from this rule. Another important difference is that O-linked glycans in 
contrast to N-linked glycans do not rely on a pre-created precursor glycan. Thus, each 
monosaccharide from the first one to be added to the polypeptide chain to the 
outermost are added individually. The innermost monosaccharide, always GalNAc, is 
linked to serine or threonine via one GalNAc transferase, belonging to a family of  
potentially as many as 24 isoenzymes (1, 71), encoded by the human genome, each with 
slightly different but sometimes overlapping specificities. 
The signal for O-linked glycosylation is not as distinct as that mentioned above for N-
linked glycosylation. Generally, the peptide stretches to be O-glycosylated contains many 
Ser or Thr units, to which the first GalNac is added, and several Pro residues. Charged 
residues are disfavored at positions -1 and +3 in regards to Ser/Thr (71), which is of 
relevance for the present work (see Paper I). These “rules” merely reflect tendencies, 
and are not sufficient for construction of a consensus amino acid sequence for O-linked 
glycosylation though much effort has been put into discovery of such a consensus 
sequence. The difficulties are not only due to the general complexity of the O-linked 
glycosylation for a given GalNAc transferase but also due to the fact that each of the 
many GalNAc transferases has its own sub-specificity (1).  
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The second sugar to be added to the GalNAc can be one of the three following: (i) α2,6-
Sialic acid, resulting in the sialyl-Tn antigen, (ii) β1,3-Galactose, resulting in a Core 1 
antigen, further addition of β1,6GlcNAc to the initial GalNAc produces the Core 2 
antigen, which will be discussed further in the thesis. (iii) β1,3-GlcNAc for synthesis of 
the Core 3 antigen, further addition of another GlcNAc in the β1,6-position produces a 
Core 4 antigen. The Core 2 and Core 4 antigens may then be subject to addition of 
β1,3/4-Gal and β1,3-GlcNAc for production of longer polylactosamine arms where sialic 
acid and fucose are terminally added producing rather complex O-linked glycans (23, 
75). 
Glycosylation topology of gC-1 
Glycoprotein C (gC) allows binding of the virion to glycosaminoglycans heparan sulfate 
(HS) and chondroitin sulfate (CS) on the cell surface (25, 44). gC is a class I 
transmembrane protein of 511 amino acid residues and is heavily glycosylated, 
expressing both N- and O-linked glycans. gC-1 is N-glycosylated at 8 of 9 possible 
glycosylation sites and has an O-glycan rich mucin domain between amino acids 55-104 
consisting of many Ser, Thr and Pro (Fig 1). The structural outcome of O-linked 
glycosylation of gC is dependent on many factors. First, the amino acid sequence is 
crucial for which of the 20 GalNAc transferases is able to add the first GalNAc (See 
above). In addition, some GalNAc transferases contain a lectin-binding domain able to 
bind to various carbohydrate epitopes, thereby prolonging the time the glycoprotein is 
in contact with the glycosyltransferases of a given compartment (76). Finally, the 
variations in the expression pattern and intracellular location of glycosyltransferases 
are of greatest importance for the specificity of the glycotope detectable on gC.  
Lewis and related antigens 
Lewis antigens are a group of fucosylated glycans and the name refers to a family 
suffering from red blood cell incompatibility, leading to the discovery of Lewis a (Lea) 
(79). Later a closely related compound, Lewis b, was discovered. Both Lea and Leb are 
expressed on the glycolipids of erythrocytes. The Lewis antigen family, consisting of 
Lewis a (Lea), Lewis b (Leb), Lewis x (Lex), Lewis y (Ley) and sialylated forms of Lex and 
Lea, is expressed on O-linked and N-linked glycans as well as on glycolipids. The Lewis 
antigens may be divided into two groups depending on their synthesis. Lea, Leb and sLea 
all are synthesized from a type 1 precursor (Galβ1-3GlcNAc) where a Fucose (Fuc) is 
added in a α1,2 or α1,4 position to synthesize the different antigens. Lex, Ley and sLex, on 
the other hand, are synthesized from a type 2 precursor (Galβ1-4GlcNAc) and Fuc is 
added to the same monosaccharide but in α1,3 position to create the type 2 Lewis 
antigens (Fig 2).  
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Fig 2. Schematic drawing of the synthesis of the Lewis antigens related to the present thesis, 
type 2 Lewis antigens.  
 
Lewis antigens as selectin ligands 
Lewis antigens are involved in several different biological processes. One of the most 
important roles of Lewis antigens in vivo are as ligands for selectins. Selectins are 
molecules expressing a lectin-like O-glycan binding domain linked in tandem to an 
epidermal growth factor-like domain, followed by varying numbers of short consensus 
repeats connected to transmembrane and cytoplasmic domains (40, 41, 66). There are 
three different types of selectins, E (endothelial) – P (platelet) - and L (leukocyte) - 
selectin. L selectins main ligand is sialyl 6-sulfo Lex but L selectin is also able to bind 
sLex. P selectin and E selectin both bind sLex and sialyl 6-sulfo Lex, though current data 
suggest that there are other undetermined ligands of E selectin (32, 48). The selectins 
bind sLex and sialyl 6-sulfo Lex, but on different glycoproteins and in slightly different 
manners. P-selectin binds the P-selectin glycoprotein ligand-1 (PSGL-1) and CD24. L-
selectin also binds PSGL-1, but is less dependent on the protein scaffold than P-selectin. 
L-selectin binds, other than PSGL-1, CD34, glycosylation-dependent cell adhesion 
molecule-1 (GlyCAM-1) and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) 
with a binding that is stronger than that of P-selectin binding (40). This binding to 
selectins is involved in the recruitment of leukocytes to sites of infection and injury, 
where the binding between sLex and selectins initiate rolling of the leukocytes, the first 
step in the process of leukocyte adhesion. 
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Lewis antigens in cancer 
Malignant cells are known to exhibit abnormal glycosylation patterns. Generally, O-
glycans of cancer cells are short and truncated compared to wild-type glycans (6). 
Monoclonal antibodies recognizing sLea, sLex and Ley on tumor cells, providing Lewis 
antigens an important role in cancer biology (6). Detection of Lewis antigens on various 
types of cancer cells are used for serum diagnostics of cancer, and have been used for 
nearly two decades by clinicians (34). 
There is a statistically significant correlation between the severity of the prognosis for 
the patient and the degree of sLex expression on many different types of cancer cells, 
also correlating with E selectin expression in the patient’s serum (34). 
Immunohistochemical studies reveal an expression of E selectin in small blood vessels 
surrounding tumors (34). Metastatic cells expressing sLea and sLex, are able to bind to 
selectins in a similar fashion to homing leukocytes, allowing for extravasation of the 
tumor cells  (33). 
The role of Ley expression on cancer cells has not yet been determined. Non-sialylated 
Lewis antigens, i.e. Ley, are able to bind dendritic cells and are involved in the T-cell 
immunological response as discussed below. If Ley on cancer cells are engaged in this 
immune response has not been investigated. Ley antibodies are currently in trail studies 
for use in cancer treatment (60, 65).  
Lewis antigens as viral receptors 
Lewis antigens are also important as viral receptors, and human noroviruses are able to 
bind to Lewis antigens causing acute gastroenteritis. Many studies have shown  that 
humans lacking a functional FUT2 gene are not susceptible to norovirus infection and 
hence do not express the norovirus receptor (47, 72). Recently, different norovirus 
strains have been found to have different specificity for histo blood-group antigens, 
resulting in a variable spreading pattern, dependent on the infectious viral strain (28, 
29). 
Fucosyltransferases 
Fucose is a key monosaccharide in Lewis antigens and related glycotopes. The genetics 
and biology of the responsible fucosyltransferases is characterized by a high degree of 
complexity. There are nine different fucosyltransferases, Fuc-T, expressed in human 
cells. The fucosyltransferases add a fucose (Fuc) in α1,2- position to galactose (Gal) 
(Fuc-TI and Fuc-TII), add a Fuc at α1,3 or 4- position to GlcNAc (Fuc-TIII, IV, V, VI, VII 
and IX) or add Fuc α1,6 to GlcNAc (core fucosylation of N-glycans) (Fuc-TVIII). The 
different fucosyltransferase genes (FUTs) are differently expressed in a cell- and tissue-
specific manner (Table 1), but still have some redundancy in function. FUT1 and FUT2 
generally use different substrates for α1,2- fucosylation, FUT1 predominately uses a 
type 2 precursor (Galβ1,4GlcNAc) while FUT2 fucosylates type 1 precursors 
(Galβ1,3GlcNAc). FUT3 and FUT5 differ from the other  α-1,3FUTs, being the only FUTs 
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able to fucosylate both type1 and type2 precursors and adds a Fuc in different positions 
depending on the precursor,  α1,4- position (for type1) and a α1,3- (for type 2) (13, 49, 
55).  
 
Table 1. Properties of the human fucosyltransferases used in this thesis. 
Gene 
(GenBank) 
Enzyme 
abbreviation/
Linkagea 
Synthesized 
Type 1 
Structuresa 
Synthesized 
Type 2 
Structuresa 
Cellular 
expression 
patterna 
HEL cell 
genotypeb 
FUT1 (H) 
(M35531) 
Fuc-TI           
Fuc (1,2) 
 H Type 2 Mesenchymal, 
erythroid 
NDc 
FUT2 (Se) 
(U17894) 
Fuc-TII 
Fuc (1,2) 
H Type 1  Epithelial cells 
(savlia and 
mucous 
membranes) 
se428se428 
FUT3 (Le) 
(X53578) 
Fuc-TIII        
Fuc (1,3/4) 
Lea, Leb, sLea Lex, Ley, sLex Epithelial cells in 
gastrointestinal 
tissue; kidneys 
Lele202. 314 
FUT4 (Lex) 
(M58596) 
Fuc-TIV         
Fuc (1,3) 
 Lex, Ley Myeloid cells; 
embryonic; 
ubiquitous 
ND 
FUT5 
(M81485) 
Fuc-TV          
Fuc (1,3/4) 
Lea, Leb, sLea Lex, Ley, sLex Low level tissue 
expression; spleen, 
gastrointestinal 
ND 
FUT6 
(M98825) 
Fuc-TVI         
Fuc (1,3) 
 Lex, Ley, sLex Gastrointestinal 
tissue; kidney; 
liver; plasma 
FUT6wtFUT6370 
FUT7 
(X78031) 
Fuc-TVII       
Fuc (1,3) 
 sLex Leukocytes; spleen FUT7wtFUT7wt 
FUT9 
(AJ238701) 
Fuc-TIX         
Fuc (1,3) 
 Lex, Ley Leukocytes; brain; 
stomach 
ND 
a (8, 13, 14, 36, 37, 64) 
b Data from the present work (III) 
c Not determined 
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Methodological considerations 
Cell culture, herpesvirus strains, and procedures for viral infection 
Throughout this thesis human embryonic diploid lung fibroblasts (HEL) cells (43) were 
used for herpes virus infectivity because this is a human, non-tramsformed, diploid cell 
line, permissive for HSV-1, CMV and VZV thus enabling comparison between the 
different herpesviruses. Low-passage cultures were used throughout the studies to 
avoid side effects that could occur in cells after many passages. For plaque titration 
assays, on the other hand, Green Monkey Kidney (GMK) cells were used for their ability 
to form easily detectable plaques using well characterized assays (9) (I). To investigate 
specific binding of HSV-1 to HS and CS murine fibroblasts L cells expressing both HS and 
CS, the CS expression variant gro2C and the HS expressing variant sog9 EXT-1 were 
used. Details for these cells are presented in (I). The wild-type viral strains used for 
herpesvirus infection are: Syn17+ (HSV-1), Towne (CMV) and patient isolate C822 
(VZV), presented more in detail in (II, III, IV). Several mutant viruses were also analyzed: 
gC mutant HSV-1114,117, originally designed for studies on HSV-1 receptor-binding (I), 
ICP0 deletion mutant dl1403 (IV), temperature sensitive ori binding protein mutant tsS 
(IV) and temperature sensitive ICP4 mutant tsK (IV). The parental strain of all HSV-1 
mutants was Syn17+. Infection of different types of cells was performed as described (I, 
II, III and IV). Cycloheximide (CHX) was used for blocking viral and cellular RNA 
translation and MG-132, a drug which inhibits the proteasome, was used. Cells were 
pretreated with drugs prior to infection (IV). 
In vitro glycosylation of gC-1 mutant 
Immunoprecipitation and subsequent analysis of the relative molecular weight of gC and 
its precursor pgC, was used to characterize gC-1 mutants with expected altered O-linked 
glycosylation. One mutant gC-1 (gC114,117) with suspected hyperglycosylation was further 
analysed in an in vitro system based on individual recombinant GalNAc-transferases and 
synthetic peptides representing a relevant part of the O-glycosylation signal of wild type 
(gCrescue)  and mutant gC-1 (gC114,117) (I). Thus, the efficacy of O-glycosylation signals was 
investigated by the ability of GalNAc transferases T1, T2, T3 and T6 to add GalNAc from 
UDP-GalNAc to the peptide. The amount of GalNAc added to specific Ser and Thr 
residues of the target peptide were assayed by MALDI-TOF MS and the specific Ser and 
Thr residues were identified by their failure to produce an expected signal during 
Edman degradation. Together MALDI-TOF and Edman degradation provide very 
detailed information regarding the position of O-glycans on the peptides as well as the 
extent of glycosylation of each site.   
Transcriptional analysis 
Analysis of gene transcription through real-time PCR was extensively described in paper 
II. The transcription of relevant host and viral genes was studied through total RNA 
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isolation on automated systems. The RNA was then subjected to real-time RT PCR, 
where normalization of  the investigated RNA against a highly expressed housekeeping 
gene proved difficult, as no mRNA transcript was found to be unaffected by HSV-1 
infection. The remaining option was to investigate total RNA and use 18S rRNA as a 
housekeeping gene, where total expression of 18S rRNA proved to be constant in herpes 
virus-infected HEL cells. Calculations of the relative RNA concentrations were 
formulated according to the 2-ΔCT (II, III).  
Lewis antigen expression 
Immunofluorescence using a confocal microscope was utilized for visualization of the 
Lewis antigens. Mouse monoclonal antibodies against sLex, Lex and Ley, and human sera 
positive for HSV-1, CMV, and VZV were bound to infected cells on teflon-coated slides. 
Secondary FITC (green) conjugated antibodies directed against mouse antibodies and 
TRITC (red) conjugated anti-human antibodies were utilized. In the present 
experimental setting confocal microscopy provided a method superior to FACS or ELISA 
for information regarding expression pattern of the glycotopes mentioned above (III, 
IV). 
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Results 
Glycosylation is important for the function of most membrane proteins, not least viral 
envelope proteins. Glycosylation influences a multitude of events from correct folding to 
specific binding of cells, bacteria or viruses. Mammalian viruses rarely encode 
glycosyltransferases, only two viral glycosyltransferases are known, encoded by bovine 
herpes virus type 4 (77) and myxoma virus (31), despite the fact that most enveloped 
viruses express glycoproteins. Glycosylation is a complicated process dependent on 
many factors, including the amino acid sequence to be glycosylated and cellular 
expression and localization of glycosyltransferases just to mention a few. One of the 
aims of the present study was to determine two of the parameters available for a 
herpesvirus to influence the O-linked glycosylation in the infected cells: By varying the 
peptide signal in viral glycoproteins for O-linked glycosylation and to influence 
expression patterns of host glycosyltransferases that determine the structural 
properties of O-linked glycans. 
O-glycosylation signal features (I)   
The well characterized HSV-1 glycoprotein gC, consisting of an O-glycan rich domain in 
the N-terminal portion of gC (Fig 3), appears to be an ideal experimental system for 
studies on the significance of the O-linked glycosylation signal of herpesvirus 
glycoproteins. The rationale behind the experiments reviewed in this section is that a 
mutant HSV-1, designated HSV114,117, originally designed for studies on the significance 
of basic amino acids for HSV-1 attachment, encodes a gC-1 that became 
hyperglycosylated as determined by its electrophoretic mobility (I).  In the mutated gC 
(gC114,117), two basic aminoacids, Arg114 and Lys117, of the gC-1 mucin domain are 
substituted for alanine. The introduced mutations surprisingly increased the molecular 
weight of gC, suggesting that the mutations caused a change in O-glycosylation rather 
than in N-linked glycosylation (I). Infection of a cell-line unable to extend O-
glycosylation further than the first GalNAc residue of O-glycans (C1300) resulted in 
wild-type and mutant gC-1 with identical electrophoretic mobility, confirming that 
amino acids 114 and 117 influences the extent of O-linked glycosylation (Fig 4).  
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Fig 3. Schematic drawing of the mucin domain of gC-1. The N-glycans are 
symbolized by diamond shapes and the possible O-glycans are symbolized by 
circles. The peptide used in Paper I is the area enclosed by a box, with the mutated 
amino acids indicated by arrows. 
One intriguing question was whether the increased O-linked glycosylation of gC114,117 is 
due to an increased number of serines/threonines becoming O-glycosylated or an 
enlargement of existing O-glycans. This was investigated using an in vitro system with 
different recombinant GalNAc-transferases and a synthetic peptide, representing the 
relevant part of the gC-1 O-linked glycosylation signal (Fig 3), including Arg114 and 
Lys117. In vitro, O-glycosylation assays, including a panel of purified GalNAc transferases, 
indicated that GalNAc T2 was most efficient in O-glycosylation of the peptide. The 
products were further assayed by MALDI-TOF and Edman degradation of the 
glycosylated peptide, where MALDI-TOF demonstrated a final GalNAc amount of 2 units 
on the gCrescue peptide and 3 units on the gC114,117 peptide (Fig 5). Edman degradation 
confirmed this result and also provided mapping data of the serine and threonine 
glycosylated residues. Thus, Ser115 and Thr119 were glycosylated on the gCrescue and the 
additional site Thr111 was completely O-glycosylated on the gC114,117 peptide (I). The 
addition of one extra O-glycan in gC114,117 is not sufficient to account for the total 
difference in molecular weight between gC114,117  and gCrescue, and there was no increase 
in sialylation between gC114,117  and gCrescue (I). Hence, the increased O-glycosylation of 
gC114,117 is due to an additional O-glycosylation site, addition of other O-glycosylation 
sites in the remaining portion of gC and/or an increased size of O-glycans in general, 
though not via addition of sialic acid.  
The altered O-linked glycosylation of gC114,117 was found to affect the ability of the viral 
attachment and social behavior of infected cells. Thus, infecting cells expressing only 
chondroitin sulfate (Gro2C), cells expressing only heparin sulfate (sog9 EXT-1) and cells 
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expressing both (L cells and GMK) with HSV114,117 and HSVrescue, showed that HSV114,117 
was less efficient in infecting cells via the CS receptor route (I). A decreased capacity to 
bind to CS also resulted in a decreased capacity for cell-to-cell spread, determined by 
plaque-size reduction assays (I). 
 
Fig 4. Positions of gC-1 and pgC-1 from HSV114,117 (M) and HSVrescue (R)-infected GMK and C1300 
cells. Positions of molecular weight markers are indicated.  
Fig 5. MALDI-TOF mass spectra of gC114,117 and gCrescue glycosylated in vitro 
by GalNAc-T2 for 0, 1 and 24h. The m/z values of differently glycosylated 
peptides are indicated. Calculated numbers of attached GalNAc residues are 
indicated within brackets. 
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Establishment of Real time RT-PCR for transcriptional analysis (II) 
Investigating expression of cellular glycosyltransferases is an important part in 
determining possible changes in glycosylation in herpesvirus-infected cells. Real time 
reverse transcriptase (RT) PCR is a powerful tool for detailed studies of transcriptional 
regulation when used correctly. Factors such as sample to sample variation in cell count 
and RNA isolation must be corrected for, preferably by utilizing transcription of cellular 
house-keeping genes for standardization. Thus, identification of a highly expressed gene 
not effected by cell differentiation or viral infection is tedious but crucial. Herpesvirus 
infection alters cellular RNA levels through a number of mechanisms and “classical” 
house-keeping genes normally used for this purpose were detected at considerably 
lower levels in herpesvirus-infected cells compared to uninfected cells (II). The only 
RNA found to be unaltered during the current conditions was 18S rRNA. An incorrect 
choice of house-keeping gene alters results with several orders of magnitude, as shown 
by analysis of gC RNA expression in HSV-1 infected cells (II). The same method was used 
to determine transcription of a glycosyltransferase, fucosyltransferase 5 (FUT5), where 
HSV-1 infection induced gene transcription 80-fold compared to uninfected cells.  
 
Lewis antigen expression in herpes virus infected cells (II, III and IV) 
The aim here was to evaluate if herpesviruses were able to modify glycosylation by 
modulating the transcriptional rates of host enzymes necessary for, particularly, O-
linked glycosylation. A relatively broad approach was applied including screening of 
GalNAc-transferases, responsible for adding the first monosaccharide to the peptide of 
the growing O-linked glycan, the so called Core 2 transferase (β1,6- GlcNAc transferase), 
sialyltransferases, and a family of fucosyltransferases. The only up-regulation detected 
was among the fucosyltransferase family, no induction was found in any of the other 
transferases investigated (Table 2). Two different expression patterns emerged, 
fucosyltransferases being the focus for herpes viral regulation, α herpesviruses HSV-1, 
HSV-2 and VZV induces transcription of FUT3, FUT5 and FUT6. This induction was also 
detected in β herpesvirus CMV infected-cells, where it was accompanied by a massive 
induction of FUT1.  
The effects of increased FUT gene transcription were investigated by 
immunofluorescence of herpesvirus-infected HEL cells. Monoclonal mouse antibodies 
against Lex, Ley and sLex along with human sera directed against HSV, VZV or CMV were 
incubated with infected and uninfected HEL cells. Green fluorescent antibodies directed 
against mouse antibodies and red fluorescent antibodies directed against human 
antibodies were used for detection using a confocal microscope (Fig 6). HSV and VZV 
induced expression of sLex with Golgi-like staining, compatible with the induced 
expression pattern of FUT genes. sLex expression could also to some extent be detected 
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on the surface of VZV-infected cells. CMV, on the other hand, induced surface-expression 
of Ley, in line with the additional extreme FUT1 transcription induction. No sLex or Ley 
expression could be detected in uninfected cells. 
Viral factors responsible for FUT5 induction 
HSV-infected cells and FUT5 induction were used as a model system for closer studies of 
the FUT3, FUT5 and FUT6 sLex induction. HSV-1 binding to the cell was not sufficient for 
FUT5 transcription induction, and tegument proteins were themselves unable to induce 
FUT5 transcription (IV). Hence, viral transcription is required for FUT5 transcription. 
The first gene to be transcribed in lytic HSV-1 infected cells is ICP0, whose role was 
explored using an ICP0 deletion mutant (dl1403). Infection of cells with wild-type HSV-1 
and dl1403 demonstrated the ICP0 gene to be involved in FUT5 transcriptional up-
regulation (Fig 7). Cycloheximide treatment of HSV-1 infected cells inhibiting protein 
translation did not inhibit FUT5 transcription (Fig 8). FUT5 transcription is massively 
induced during CHX treatment as early as 2 hours p.i., though MG-132 treatment, 
inhibiting the proteasome, together with CHX was unable to induce FUT5 (preliminary 
data, IV). This may be a result of possible MG-132 induced inhibition of ICP0 function or 
effects of MG-132 on the transcriptional machinery (19, 61). All available data here 
support the latter explanation, but does not definitely rule out that MG-132 effects on 
ICP0 protein, demonstrated in Fig 8 of paper IV, are involved in FUT5 transcription. This 
option may be considered owing to the known function of ICP0 protein as an 
ubiquitinylating agent associated with proteasomal degradation of ND10 (21), but as 
MG-132 inhibited FUT5 transcription together with CHX at 2.5h p.i., time points when 
ICP0 is first detected in the infected cell (63) an effect of the ICP0 protein on FUT5 
transcription this early is unlikely. In conclusion, the initiation of FUT5 transcription is, 
therefore an effect of ICP0 RNA.  
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Table 2. A summary of Real time RT-PCR of glycosyltransferase expression in 
HSV-1-, VZV- and CMV-infected HEL cells. Data from (II, III, IV) if not otherwise 
stated. → indicates no transcriptional induction; ↗ indicates slight 
transcriptional increase; ↑ represents a large transcription induction. 
Transferase HSV-1 VZV CMV 
FUT1 → → ↑ 
FUT2 → → → 
FUT3 ↑ ↑ ↑ 
FUT4 → → → 
FUT5 ↑ ↑ ↑ 
FUT6 ↑ ↑ ↑ 
FUT7 → → → 
FUT9 ↗ → ↗ 
ST3GalIIIa → → → 
ST3GalIVa → → → 
GST2b - - → 
C2GnTc → - → 
GalNAc-T3d - - → 
GalNAc-T6d - - → 
a α2,3-sialyltransferase III and IV (preliminary data, III) 
b 6-O sulfotransferase (preliminary data) 
c β1,6-GlcNAc transferase, Core 2 transferase (preliminary data) 
d GalNAc transferase T3 and T6 (preliminary data) 
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Fig 6. Immunofluorescence images from HSV-1-, VZV- and CMV-infected cells. Green secondary 
antibodies were used for detection of Lewis antigens and red secondary antibodies were used 
for detection of viral antigens. The white bar represents 20µm (III, IV). 
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Fig 7. Expression of FUT5, ICP0 and ICP4 in cells infected with wild-type HSV-1, dl1403 and 
uninfected cells. The ICP0 PCR system was designed to detect the non-deleted portion of 
ICP0(IV). 
 
Fig 8. Detection of FUT5 RNA in cells infected with HSV-1 and uninfected 
cells. The cells were treated with CHX, MG-132 or ethanol. The cells were 
infected 9h (IV). 
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General Discussion 
The present work describes the mechanism behind herpesvirus-induced expression of a 
family of biologically active carbohydrates on the cell surface. Most studies of 
glycosylation in virus-infected cells regards N-glycans on viral glycoproteins, where the 
glycans are crucial for general functions for example correct protein conformation (12, 
38, 51, 53, 58, 69). Here, it is described how a virus actively can determine the structure 
of O-linked glycans, a relatively new field in virology. These glycans most likely have 
different roles in the infected cell compared to the N-linked glycans. One new viral 
strategy implies recruitment of specific O-linked glycans that actively interact with and 
modulate various immune- and non-immune cells in the infected host, data from (III, IV)  
(26, 27, 33). This is at variance with the immunologically more passive viral use of host-
specific N-linked glycans for masking of viral epitopes from neutralizing antibodies (68).  
As discussed in more detail below, herpesviruses are able to induce host factors 
necessary for expression of new O-linked glycans very early in the infection cycle, 
epitopes that do not appear in the uninfected cell (II, III, IV). A natural consequence of 
this is that early virus-induced alterations of glycosylation, prior to de novo viral protein 
synthesis, will target cellular proteins (or glycolipids), whereas later manipulation of 
glycosylation mainly effects viral glycoproteins. During HSV-1 infection, substantial 
amounts of viral glycoproteins are detected as early as 5 h p.i., whereas VZV and CMV 
glycoproteins are expressed later in the infection and for longer periods of time. The 
present results therefore suggest that the majority of the virus-induced glycans in HSV-1 
infected cells relatively soon are exposed on viral glycoproteins whereas in particular 
CMV-induced carbohydrates may reside on host-specified glycoproteins for a longer 
period of time after infection (III, IV).  
Herpesviruses are able to control glycosylation in at least two different manners 
explored in the present work: (i) As reviewed above, the signal requirement for O-linked 
glycosylation of mucin-like regions of glycoproteins are complex and to some extent 
heterogenous, owing to the large number of human GalNAc-transferases with capacity 
to initiate O-linked glycosylation. Thus, one viral strategy for controlling the extent of O-
linked glycosylation could be via variations in the peptide signals of a mucin region of a 
viral glycoprotein (I). (ii) Viruses may also be able to control glycosylation by inducing 
transcription of critical host cell genes, resulting in expression of specific carbohydrate 
antigens (III, IV). 
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Fig 9.  Summary of the fucosyltransferases involved in induction of Ley and sLex in CMV- and 
HSV-1, VZV-infected cells respectively, represented in darker shades.  
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The present results suggest that the O-linked glycosylation signal in the mucin region of 
HSV-1 gC-1 is optimized for its interactions with the cell during the infectious cycle and 
that it is not a viral strategy to maximize the extent of O-linked glycosylation in the 
mucin region of gC-1. This is best illustrated by the finding that the consensus O-linked 
glycosylation signal of gC-1, for a number of sequenced HSV-1 isolates, contain two basic 
amino acids, whose presence is not compatible with utilization of all available Thr 
residues, especially the non-glycosylated Thr111, in the mucin domain for O-linked 
glycosylation (I). This restriction was overcome by creating an HSV-1 mutant, where 
these basic amino acids were substituted by Ala, which results in hyperglycosylated gC-1 
compared to its wild-type counterpart. The large difference in the extent of O-linked 
glycosylation, corresponding to 8,000 daltons, is only partly explained by the 
observation that non-glycosylated Thr111 in the wild type signal environment is 
switched to a 100% efficient glycosylation acceptor by the induced mutations (I). O-
linked glycans of 8,000 daltons correspond to at least 20 monosaccharides, which have 
not been described for viral glycoproteins. It is therefore reasonable to assume that the 
mutations induced also increased the extent of glycosylation of several O-linked glycans 
in the mucin region of gC-1. Alternatively, additional available non-glycosylated Ser/Thr 
regions in the wild type signal have been recruited for glycosylation. The latter 
hypothesis is supported by findings that a few of the GalNAc-transferases, adding the 
innermost GalNAc of O-linked glycans, contain lectin domains that prolong the enzyme-
glycoprotein interaction, thereby increasing the efficacy of O-linked glycosylation (24). 
The extent of gC-1 O-glycosylation appears to be biologically relevant for the 
interactions between HSV-1 and the infected cell, where two phenomena are 
discernible: Hyperglycosylation of gC-1 (as introduced by changing the basic amino 
acids in the O-glycosylation signal) resulted in (i) impaired binding to an important 
receptor, chondroitin sulfate and (ii) altered cell-to-cell spread as illustrated by 
decreased plaque size (I). It is therefore tempting to speculate that the length and O-
glycosylation density of gC-1 is adjusted for optimal performance regarding HSV-1 
attachment to permissive cells and subsequent cell-to-cell spread of progeny virus.  
It is evident from these studies that sequence variation of the O-glycosylation signal is a 
blunt tool for viral regulation of glycosylation that does not allow for a specific induction 
of defined carbohydrate epitopes such as Lewis or ABH antigens. A more appropriate 
strategy would be to induce synthesis of key glycosyltransferases that are essential for 
formation of the intended glycotopes. As previously mentioned, no glycosyltransferase 
encoded by a human virus has been identified, so the only remaining way for a human 
virus to induce specific glycotopes in the infected cell would be to activate the dormant 
host genes, encoding the relevant glycosyltransferases. The approach used here was to 
study transcriptional induction of glycosyltransferase genes, whose gene products could 
be implied in the induction of virus-specific changes in O-linked glycosylation. Initially, a 
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broad search was performed including genes encoding GalNAc-transferases 
(preliminary data) responsible for the addition of the innermost GalNAc, Core 2-
transferases (preliminary data) necessary for formation of a specific branching of O-
linked glycans, sialyltransferases (III) and fucosyltransferases (II, III, IV), both 
responsible for completing the terminal structure of an O-linked glycan (Table 2). Owing 
to their significance for expression of cell surface glycans, it was expected that the 
transcription of genes, representing several of these families should be subject to 
regulation by the infecting herpesvirus. Surprisingly, only one family of 
glycosyltransferases, the fucosyltransferase genes, was found to contain representatives 
whose transcription was induced by several orders of magnitude after infection with 
different herpesviruses. As discussed below, the different transcription pattern of 
fucosyltransferase genes was correlated to a compatible expression of different virus-
induced glycotopes in the infected cells. This is in line with a notion that herpesviruses 
use regulation of host glycosyltransferase gene transcription for intended expression of 
specific carbohydrate neoantigens, in particular of the Lewis lineage, at the cell surface 
and that the fucosyltransferase genes represent a family of strategic importance for this 
purpose.  
How is the herpesvirus-induced expression of different Lewis antigens accomplished? 
All of the herpes viruses investigated, HSV-1, VZV and CMV, induce transcription of 
dormant FUT3, FUT5 and FUT6 (II, III, IV). This pattern of fucosyltransferase induction 
results in a neo-expression of sLex in HSV-1 and VZV-infected cells (Fig 9, lower panel). 
From the present data it is however not possible to deduce if any of these three FUT 
genes is more important than the others for sLex induction. In addition to these three 
FUT genes, CMV but none of the other investigated herpesviruses also massively up-
regulate FUT1 (III). FUT1 induction introduces a dramatic change in the glycosylation 
landscape, it prevents sialylation of type 2 precursor, i.e. the final substrate for FucT-III, 
V or VI directly resulting in sLex formation. Instead, the type 2 precursor is α1,2-
fucosylated by FucT-I in CMV-infected cells following FucT-III, V or VI dependent α1,3-
fucosylation resulting in Ley (Fig 9, upper panel).  
The herpesviral use of FucT-III, V or VI for virus-induced synthesis of Lewis antigens 
represents a different strategy than that used by HTLV-1, a human cell transforming 
virus, which also induces sLex. Thus, HTLV-1 up-regulates FUT7 transcription (26, 27) 
whose transcription remains more or less constant at a low level in herpesvirus-infected 
cells (III, IV). This allows for sLex synthesis, but does not permit a switch to Ley, even 
during high FucT-I activities, because in contrast to FucT-III, V and VI, FucT-VII is strictly 
dependent on a sialylated precursor (5, 13). It is tempting to speculate that the induction 
of FUT3, 5 and 6 represents a common ancestrial feature among herpesviruses, and that 
the β herpesvirus-induced activation of FUT1 is a more recent event in order to recruit 
Ley as an active glycotope of the infected cell.  
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One intriguing question pertains to how viruses increase the transcriptional rate of 
selected cellular genes despite the fact that many herpesviruses activate powerful 
mechanisms aiming at shutting off host cell macromolecular synthesis, including 
transcription of infected cell genes. This problem was addressed by exploring the nature 
of the viral factors responsible for HSV-1 induced transcription of host 
fucosyltransferase genes, using FUT5 as a model gene. From these studies it was clear 
that the most important difference, as to viral factors engaged in induction of sLex 
between HTLV-1 and HSV-1, is that the former utilizes a classical retroviral 
transactivator protein, Tax, which induces transcription via a CRE sequence in the 
human FUT7 promoter (26, 27, 33). This is in contrast to the somewhat surprising 
mechanism used by HSV-1 for activation of FUT5 demonstrated here (IV), requiring 
specific viral RNA and thus active in the absence of viral protein synthesis.  
The conclusion that ICP0 RNA is a key actor is based on the finding that FUT5 
transcription was induced during CHX treatment of infected cells and by the fact that 
FUT5 transcription was an immediate early process with kinetics congruent with ICP0 
transcription (IV). It is important to note that binding of the virion to the cell surface or 
tegument proteins alone is not sufficient for FUT5 transcriptional induction, though 
tegument proteins are necessary for initiation of transcription of viral genes (IV). It is 
unlikely that other viral factors, e.g. RNA encoded by other HSV-1 genes, are involved in 
FUT5 induction since the ICP4 gene is not necessary for FUT5 induction (IV), and ICP0 
RNA induction of other HSV-1 genes is not known.  
The suggestion that ICP0 RNA is able to be processed to miRNAs (57) is intriguing and it 
could be worthwhile to address the possibility that ICP0-derived miRNAs are involved in 
the induction of FUT5. The notion that ICP0 RNA rather than the translated gene product 
is responsible for inducing cellular activities is not new. Thus, ICP0 RNA alone may 
induce apoptosis in HSV-1-infected cells (67), a process later reversed via expression of 
several different HSV-1 proteins (Reviewed by (20) and (52). This is, however, the first 
demonstration of a viral RNA, acting as a specific inducer of a dormant host 
glycosyltransferase gene. 
The HSV-1 strategy to use a viral RNA, and in particular an RNA encoded by an IE gene, 
for the initial step of FUT5 induction offers advantages for the virus compared to the 
Tax-dependent HTLV-1 induced activation of FUT7. Firstly, this is a prerequisite for a 
very rapid activation of the host FUT5 gene as the concept of an RNA inducer eliminates 
delays caused by RNA transport to the cytoplasm, translation, and transport of the 
translated protein to the nucleus, inevitable and time-consuming processes associated 
with immediate early viral proteins as inducers of intranuclear activities. Our finding 
that 2-fold levels of FUT5 RNA is detected as early as one hour p.i. underscores that HSV-
1 induction of FUT5 transcription indeed is a rapid process. Moreover, the RNA concept 
also permits that at least the first step of the virus-induced activation of FUT5 takes 
place without any presentation of viral B and T cell epitopes in the newly infected cells. 
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This latter aspect may be of relevance for the latent or persistent state of HSV-1 in the 
infected neuron, where it at least theoretically should be possible for the viral genome to 
influence the cell surface glycotopes of the latently infected neuron by a short pulse of 
ICP0 transcription. The possible significance of this aspect is illustrated by the multitude 
of surface glycotopes of relevance for the functional status of neuronal cells (30, 80). 
The conclusions presented above concern only the very first step in the herpesvirus 
control of FUT gene expression. In other words, the ICP0 RNA-dependent activation of 
host fucosyltransferase genes, here exemplified by FUT5, is followed by several 
consecutive steps in the virus-induced regulation of sLex expression over time. For 
example, inhibition of viral DNA synthesis is associated with hyperexpression of FUT5 
RNA (II, IV), compatible with the notion that viral late proteins are also engaged in 
attenuation of FUT5 transcription (II). It should also be kept in mind that the ICP0 
protein, aside from being the first transcribed gene during lytic viral infection, degrades 
ND10 sites, releasing transcriptional factors in the nucleus that could be of relevance for 
the continued regulation of FUT5 transcription. This is noteworthy considering the 
analogies and differences between HSV-1 and HTLV-1 regarding virus-induced 
neoexpression of sLex, mentioned above. Thus, the FUT7-inducing HTLV-1 protein, Tax, 
acts on ND10 in a similar fashion to ICP0, by disruption of ND10, though via different 
mechanisms and thereby activating CREB pathways (3). The possibility that there exist 
similarities in at least the later parts of the transcriptional regulation behind sLex should 
therefore not be overlooked. It is therefore reasonable to assume that virus-induced 
regulation of sLex expression over time involves several points for viral control of which 
the ICP0 RNA-dependent FUT5 activation represents the first step.  
The use of FUT5 as a model gene does not confirm that FUT3 and FUT6 are activated via 
the same mechanism as FUT5. But, there is at least a theoretical possibility for a 
regulatory element to participate in activation of FUT3, FUT5 and FUT6 transcription 
simultaneously because all three genes are situated on the same chromosome in close 
proximity of one another (10, 14). The likelyhood of this scenario may be evaluated in 
part by investigating FUT3 and FUT6 transcription using ICP0 and ICP4 HSV-1 mutants 
along with CHX treated cells. However, there are data discouraging the notion of co-
induced transcription of the FUT3, FUT5 and FUT6 genes, because expression of these 
genes varies amongst different organs and cell types (8).  On the other hand, the 
possibility cannot be excluded a priori that the thorough re-organization of the 
transcription program induced by herpesvirus infection, including manipulation of 
histone binding regions and enhancer proteins, may pave the way for a mutual up-
regulation of all three FUTs.  
How do herpesviruses benefit from the specific induction of Ley and/or sLex at the 
surface of the infected cell? Several putative functions of these glycotopes in the viral 
context probably can be obtained from studying a far more explored system: the 
metastatic tumor cell. The glycotopes sLex is often exposed at the surface of circulating 
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tumor cells with a primary task to induce attachment to the endothelial cells and 
subsequent extravasation and colonization of peripheral tissue (16, 45, 46). During 
conventional viremia, the naked viral particles spread in the circulation are threatened 
by neutralizing antibodies and other immune factors. A circulating cell, infected with 
herpesviruses such as CMV or VZV, is relatively long-lived and could therefore serve as a 
Trojan horse for the genome of the infecting virus, rendering it inaccessible for immune 
effectors, not least circulating neutralizing antibodies. Virus-induced exposure at the 
infected cell surface of sLex on strategic occasions in the absence of antigenic viral 
proteins would provide a mechanism not only for adhesion of the infected cell to the 
endothelial wall but also for recruiting the selectin-dependent machinery for 
extravasation and access to the final tissue target. So far the only proven viral 
application of this strategy concerns HTLV-1 where the amount of virus-induced sLex at 
the surface of the virus-transformed cells is directly correlated to their ability to 
colonize skin cells. In analogy, the viremic spread of VZV to the skin is caused not 
primarily by circulating virus particles, but by circulating VZV-infected tonsillary 
memory T-cells. However, the possible role of VZV-induced sLex in this process remains 
to be elucidated. 
The exact function of Ley expression on tumor cells is enigmatic and not as well 
understood as that of sLex, but yet, its biological significance has been emphasized by 
inhibitor studies in animal models (Reviewed in (17)). One recently discovered function 
with possible relevance for interactions with microbial agents and the immune system is 
that Ley is able to bind to dendritic cells (DC) via DC-SIGN (Dendritic cell-specific ICAM-
3-grabbing nonintegrin), as are all non-sialylated Lewis antigens (2). Interestingly, 
several pathogens causing chronic infection, including Mycobacterium tuberculosis, 
Schistosoma mansoni and Helicobacter pylori have developed a Lex-dependent strategy 
for causing a Th1 to a Th2 shift in the T-cell response via a DC-SIGN-dependent 
mechanism (2, 18, 78). CMV also causes chronic infection and virus-induced Ley could 
interact with DC-SIGN in the same manner with the potential to shift the T-cell response 
to Th2, although it remains to be elucidated whether Ley is fully compatible with Lex also 
in DC-SIGN function. Thus, studies on the DC response to CMV infected cells regarding 
cytokine expression may be able to shed light on the significance of Ley on CMV-infected 
HEL cells. 
The profound significance of sLex and Ley for tumor progression has stimulated the 
development of chemotherapeutic agents based on interference with these glycotopes. 
These strategies are based on development of humanized monoclonal antibodies to sLex 
or Ley, of stable hapten glycotopes, and of specific inhibitors with capacity to interfere 
with biosynthesis of these agents. A few leads have been brought to clinical trials (65). 
Should a similar active role for Lewis antigens also be established for herpesvirus 
infection then a completely new arsenal of therapeutics of low toxicity may provide 
improved treatment of herpesvirus infections, not least in immunocompromised 
patients.   
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The herpes simplex virus type 1 (HSV-1) glycoprotein gC-1 is
engaged both in viral attachment and viral immune evasion
mechanisms in the infected host. Besides several N-linked
glycans, gC-1 contains numerous O-linked glycans, mainly
localized in two pronase-resistant clusters in the N-terminal
domain of gC-1. In the present study we construct and char-
acterize one gC-1 mutant virus, in which two basic amino
acids (114K and 117R) in a putative O-glycosylation sequon
were changed to alanine. We found that this modification did
not modify the N-linked glycosylation but increased the con-
tent of O-linked glycans considerably. Analysis of the O-
glycosylation capacity of wild-type and mutant gC-1 was
performed by in vitro glycosylation assays with synthetic
peptides derived from the mutant region predicted to present
new O-glycosylation sites. Thus the mutant peptide region
served as a better substrate for polypeptide GalNAc-
transferase 2 than the wild-type peptide, resulting in increased
rate and number of O-glycan attachment sites. The predicted
increase in O-linked glycosylation resulted in two modifica-
tions of the biological properties of mutant virus—that is, an
impaired binding to cells expressing chondroitin sulfate but
not heparan sulfate on the cell surface and a significantly
reduced plaque size in cultured cells. The results suggested
that basic amino acids present within O-glycosylation signals
may down-regulate the amount of O-linked glycans attached
to a protein and that substitution of such amino acid residues
may have functional consequences for a viral glycoprotein
involving virus attachment to permissive cells as well as viral
cell-to-cell spread.
Key words: attachment/heparan sulfate/O-linked/
plaque size
Introduction
The herpes simplex virus type 1 (HSV-1)-specific glyco-
protein gC-1 is present in practically all clinical HSV-1
isolates and plays important roles during establishment of
HSV infection in humans despite the fact that this glyco-
protein is dispensable for viral replication in cell culture
(Hidaka et al., 1990; Liljeqvist et al., 1999; Olofsson,
1992). Thus gC-1, together with another HSV-1 glyco-
protein, gB-1, is responsible for viral binding to cell surface
heparan sulfate, which is the primary viral receptor (Gerber
et al., 1995; Herold et al., 1991; Herold and Spear, 1994).
Moreover, gC-1 is exclusively responsible for viral binding
to an alternative receptor of glycosaminoglycan nature, that
is, chondroitin sulfate (MaÊrdberg et al., 2002). Finally, gC-1
constitutes a receptor for factor C3b of the complement
system, thereby contributing to HSV-1 immune evasion
mechanisms (Friedman et al., 1986, 1996).
Being a highly glycosylated protein, gC-1 contains nine
N-linked glycosylation sites of which at least eight are util-
ized and equipped with complex type glycans exclusively,
ranging from di- to tetraantennary structures (Olofsson
et al., 1999; Rux et al., 1996). In addition, gC-1 contains
numerous O-linked glycans, most of which are localized in
two pronase-resistant clusters in the N-terminal part of
gC-1 (Biller et al., 2000; Dall'Olio et al., 1985; Olofsson,
1992). One possible function of these O-linked glycans is to
contribute to an extended shape of gC-1, thereby facilitating
contacts between virion-associated gC-1 and its different
ligands (Stannard et al., 1987). The clustered O-linked gly-
cans of gC-1 may also have other functions, including direct
glycoepitope signaling to effectors of the immune system.
In this context it is intriguing that another herpes virus,
for instance, bovine herpes virus type 4, encodes a virus-
specific glycosyltransferase, b-1,6-N-acetylglucosaminyl-
transferase (core 2 transferase), which is engaged in
formation of immunologically active selectin receptors of
O-linked glycan nature (Markine-Goriaynoff et al., 2003;
Vanderplasschen et al., 2000). Finally, the O-glycosylated
stretches of gC-1 in the vicinity of, say, the heparan sulfate±
binding domain (MaÊrdberg et al., 2001) may affect its bind-
ing specificity.
The biosynthesis of O-linked glycans is initiated by the
addition of N-acetylgalactosamine (GalNAc) moieties to
serine and threonine residues of a completely translated
and folded polypeptide chain, a reaction catalyzed by 1 of
at least 13 distinct cellular UDP-GalNAc:polypeptide
GalNAc-transferases, which are localized throughout the
Golgi apparatus (Hassan et al., 2000a). These GalNAc-
transferase isoforms have different but partly overlapping
peptide acceptor substrate specificities, and they are differ-
entially expressed in cells and tissues (Gruenheid et al.,
1993), and gC-1 appears to serve as substrate for multiple
human GalNAc-transferases (Biller et al., 2000). This sug-
gests that gC-1 will become O-glycosylated in any cell type
included in the broad host cell range of HSV-1.
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Here we report that a minor modification of a glycosyla-
tion signal of gC-1, that is, substituting alanines for two
basic amino acids, resulted in major changes in the extent
of O-linked glycosylation. Moreover, this modification
changed the biological properties of mutant virus in two
different ways, for instance, altered pattern of adsorption to
primary glycosaminoglycan receptors and altered plaque
morphology, indicating differences in the complex process
of viral cell-to-cell spread.
Results
Glycosylation status of gC-1 from HSV-1 with a
modified O-glycosylation signal
During screening of HSV-1 mutants with modified gC-1,
where alanine was substituted for basic amino acids, we
found one mutant virus (HSV-1gC-1(114K,117R)A) where gC-1
displayed a significantly lower electrophoretic mobility,
indicating a significantly larger apparent molecular weight
(~8±9 kDa) compared with gC-1 specified by corresponding
wild-type virus (HSV-1Rescue) (Figure 1). This difference
could not be explained by the mere substitutions themselves
because the theoretical peptide molecular weight of mutant
gC-1 is in fact lower than wild-type gC-1. Because gC-1 is
highly glycosylated it was initially considered conceivable
that the mutation interfered with addition or processing of
N-linked or O-linked glycans, although the mutations did
not alter any of the putative N-glycosylation sites per se. To
asses if N-glycan processing was affected mutant and rescue
gC-1 were treated with N-glycanase (Figure 1, N-gly lanes).
N-glycanase treatment resulted in increased electrophoretic
mobilities of the rescue as well as the mutant gC-1, indicat-
ing that the enzyme released N-linked glycans from gC-1.
However, the difference in electrophoretical mobility
mutant and rescue gC-1 remained, demonstrating that dif-
ferences in the number or composition of N-linked glycans
were not responsible for the difference in electrophoretical
mobility between gC-1Rescue and gC-1(114K,117R)A.
In contrast to the differences in mobility between com-
pletely glycosylated wild-type and mutant gC-1 another
picture was observed for the precursor gC-1 (pgC-1)
band (Figure 1), which has been demonstrated to
contain immature high-mannose N-linked glycans but
no O-linked glycans (Biller et al., 2000; Olofsson et al.,
1983; Serafini-Cessi et al., 1984; Sommer and Courtney,
1991). Thus mock-treated mutant and wild-type pgC-1
demonstrated identical eletrophoretic mobility, which
was the case also for N-glycanase-treated (and hence
more rapidly migrating) mutant and wild-type pgC-1
bands. The separation into two very close bands of
N-glycanase-treated pgC-1Rescue and pgC-1(114K,117R)A,
respectively, was occasionally seen and may correspond
to pgC with or without the signal peptide sequence
present. The results obtained for gC-1 ruled out that
possible differences in complex type N-linked glycans
were responsible for the high-molecular-weight phenotype
of gC-1(114K,117R)A, so the present results suggested
that O-linked glycans rather than N-linked glycans
accounted for the size difference between gC-1Rescue and
gC-1(114K,117R)A.
This was further evaluated by comparing the electro-
phoretic mobilities of gC-1Rescue and gC-1(114K,117R)A pro-
duced in C1300 cells, a mouse neuroblastoma cell line with a
general deficiency in galactosyltransferases (LundstroÈm
et al., 1987b). Pertinent here is that all O-linked glycans of
gC-1 produced in C1300 cells constitute GalNAc mono-
saccharides, a few of which are sialylated, which should
be compared with a variety of differently sized O-linked
glycans up to at least tetrasaccharides that are associated
with gC-1 produced in African green monkey kidney
(GMK) cells (LundstroÈm et al., 1987a,b). There was no
demonstrable difference in electrophoretical mobility
between gC-1Rescue and gC-1(114K,117R)A produced in
C1300 cells (Figure 2), confirming that the difference in
electrophoretic mobility indeed was caused by a higher
content of O-linked glycans in gC-1(114K,117R)A: In C1300
cells, the possible extra O-linked glycosylation of
Fig. 1. Effects of N-deglycosylation of wild-type and mutant gC-1.
Immunoprecipitates of gC-1 produced in HSV-1gC-1(114K,117R)A- or
HSV-1Rescue-infected cells were subjected to N-glycanase (N-gly) or
mock treatment. The solubilized glycoproteins were separated by
SDS±PAGE in gradient gels and the protein bands were visualized by
immunoblot, using a gC-1-specific monoclonal antibody (Olofsson
et al., 1983). Wild-type (R) and mutant (M) gC-1 were analyzed.
Positions of molecular weight markers and gC-1 and pgC-1 are indicated.
Fig. 2. Positions of gC-1 and pgC-1 from HSV-1gC-1(114K,117R)A- (M) or
HSV-1Rescue-infected cells (W), respectively. The solubilized
glycoproteins were separated by SDS±PAGE using homogenous gels,
and the protein bands were visualized by immunoblot using a
gC-1-specific monoclonal antibody. Glycoproteins from virus-infected
GMK and C1300 cells are depicted. Positions of molecular weight
markers and gC-1 and pgC-1 are indicated.
K. MaÊrdberg et al.
572
gC-1(114K,117R)A was obviously insufficient to induce a
corresponding shift for the gC-1 variants produced in
C1300 cells. In addition, this result suggested that the dif-
ference in electrophoretic mobility between gC-1Rescue and
gC-1(114K,117R)A, produced in GMK cells, reflected not only
a larger number of but also physically larger O-linked
glycans of mutant gC-1.
The influence of the gC-1(114K,117R)A mutation on the
content of sialic acid in gC-1 was analyzed. Unlabeled
glycoprotein extracts from HSV-infected GMK cells
were treated with N-glycanase in the presence or absence
of sialidase, separated on sodium dodecyl sulfate±
polyacrylamide gel electrophoresis (SDS±PAGE), and
subjected to immunoblotting (Figure 3). Two distinct
bands were detected for the extracts of each virus: One
sharp strong band represented essential unglycosylated
pgC-1, owing to N-glycanase treatment, and one broader
band representing gC-1 containing O-linked glycans but
not N-linked glycans. The strong appearance of the pgC-1
band reflected that the linear epitope used as a target
for immunoblotting was partially hidden in completely
glycosylated gC-1 (SjoÈblom et al., 1992). The sialidase
treatment did not result in any consistent and reproducible
shift in electrophoretic mobility of gC-1(114R,117K)A or
gC-1Rescue.
To further explore possible differences in sialic acid con-
tent of gC-1 O-linked glycans, we determined the amount
of radioactivity released by sialidase treatment of affinity-
purified [3H]-GlcN-labeled gC-1 produced in GMK and
C1300 cells, respectively. We have previously shown that
gC-1 from C1300 cells does not contain any N-glycan-
associated sialic acid, but the materials originating from
GMK cells were treated with N-glycanase prior to sialidase
treatment to ensure that only sialic acid of O-linked glycans
was assayed. The released radiolabeled sialic acid was sepa-
rated from remaining glycoprotein by Sephadex G25 gel
filtration (Figure 4). A small but reproducible difference in
the relative content of sialic acid between gC-1Rescue (7.5%±
8.0%) and gC-1(114R,117K)A (10.0%±10.5%) was observed,
whereas no such difference in the relative sialic acid content
was noted for the corresponding gC-1 preparations from
GMK cells.
Prediction of O-glycosylation sites in synthetic peptides by
in vitro analysis of the O-glycosylation capacity of
multiple human GalNAc-transferase isoforms
Synthetic peptides representing the O-linked glycosylation
signal delimited by amino acids 106 and 124 were analyzed
as substrates for individual, purified human GalNAc-
transferases (Bennett et al., 1998; Biller et al., 2000). A
wild-type peptide (representing rescue virus) as well as a
peptide containing the gC-1(114K,117R)A mutations were ana-
lyzed with GalNAc-T1, -T2, -T3, or -T6, respectively. The
wild-type and the mutant peptide were readily glycosylated
by GalNAc-T2, however, the reaction velocity with the
mutant peptide was considerably higher than with the
wild-type peptide (Table I). The three other enzyme iso-
forms investigated demonstrated only low catalytic activ-
ities with both the wild-type and mutant gC-1 peptide
substrates (data not shown).
The difference in velocity of the glycosylation reaction
with GalNAc-T2 with the mutant peptide prompted us to
assess the final product obtained with GalNAc- T2. Matrix-
assisted laser desorption/ionization time-of-flight mass
Fig. 3. Immunoblot of proteins of the gC-1 family, treated with
N-glycanase (all) and sialidase (s), and separated by homogenous
SDS±PAGE. Lanes representing mock-treated glycoproteins are
indicated (ÿs). Sialidase efficacy was confirmed by release of radiolabel
as described in the legend to Figure 4.
Fig. 4. Sialidase treatment of [3H]-GlcN-labeled gC-1 purified from
HSV-1gC-1(114K,117R)A- or HSV-1Rescue-infected C1300 cells and GMK
cells, respectively. The gC-1 preparations from GMK cells were treated
with N-glycanase prior to sialidase treatment. Released [3H]-GlcN label
was detected in the totally included volume of Sephadex G25 gel
filtration and is expressed as percent of total gC-associated radiolabel.
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spectrometry (MALDI-TOF MS) of the products revealed
important differences. There are in total four potential
O-glycan sites in the analyzed peptide substrates, and we
found that GalNAc-T2 produced GalNAc-glycopeptides
after prolonged incubation containing 2 moles of GalNAc
with the rescue peptide and 3 moles of GalNAc with the
mutant peptide (Figure 5 and Table II). Sites of O-glycan
attachments were analyzed by Edman degradation. Initial
analysis of number of moles GalNAc incorporated by
MALDI-TOF showed GalNAc-T1 and -T2 to produce
glycopeptides containing one to two (rescue peptide) and
two to three (mutant peptide) GalNAc residues, respec-
tively. The sequencing results, which are presented in
Table II, indicated that T111, S115, and T119 of the mutant
peptide and that S115 and T119 of the rescue peptide incor-
porated GalNAc residues. This conclusion is in line with the
MS results (Figure 3). Evidence for glycosylation of T110
was found neither for the wild-type nor the mutant peptide.
Modified O-linked glycosylation signal and HSV-1
replication in cell culture
We also determined whether the altered glycosylation influ-
enced HSV-1gC-1(114K,117R)A replication in cell culture. This
was explored on two levels, that is, influence of the mutation
on (1) interactions between HSV-1 and the primary recep-
tor, using an in vitro assay for attachment to permissive
Table I. In vitro O-glycosylation of gC-1 wild-type and mutant peptide
substrates by human recombinant GalNAc-T2
GalNAc-T2 activitya
Peptide substrates 200 mMb 800 mM
gC-1Rescue
106PKNNTTPAKSGRPTKPPGP124 184 558
gC(114K, 117R)A
106PKNNTTPAASGAPTKPPGP124 1466 3402
a
Expressed as pmol/min. Background values without exogenous
substrate subtracted.
b
Peptide substrate concentration; 0.25 mU of enzyme per reaction was
used and the reaction time was 1.0 h.
Fig. 5. MALDI-TOF mass spectra of synthetic wild-type and mutant gC-1 peptide glycosylated in vitro by GalNAcT-2 for 0 h, 1 h, and 24 h. The
m/z values of peaks of differently glycosylated peptides are indicated. Calculated numbers of attached GalNAc residues are indicated within brackets.
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cells; and (2) cell-to-cell spread of newly produced virus as
manifested in differences in plaque morphology. This latter
phenomenon involves mainly other glycoprotein-dependent
processes than binding of free virus to cells, which is out-
lined more in detail later. Owing to the role of gC-1 in HSV-1
binding to cell surface heparan sulfate and chondroitin
sulfate, an analysis of the attachment kinetics of mutant
and rescue virus was performed (Figure 6). The target cells
were GMK cells, mouse L cells, and two mutant cells of L
cell origin, that is, cells synthesizing chondroitin sulfate but
not heparan sulfate (Gro2C cells), and cells synthesizing
heparan sulfate but not chondroitin sulfate (sog9 EXT-1
cells) (Gruenheid et al., 1993; McCormick et al., 1998).
We found that the adsorption graphs of HSV-1gC-1(114K,
117R)A and HSV-1Rescue were overlapping over a wide range
of virus concentrations for all cells analyzed except for
Gro2C cells, where HSV-1gC-1(114K,117R)A demonstrated a
significantly decreased adsorption ability as compared with
Table II. Analysis of number of GalNAc residues incorporated and sites of occupancy with GalNAc-T2
GalNAc-T2
Acceptor peptide Amino acid sequence GalNAc incorporateda Acceptor sitesb
gC-1Rescue 106PKNNTTPAKSGRPTKPPGP124 1/2 S
115,T119
gC(114K, 117R)A 106PKNNTTPAASGAPTKPPGP124 2/3 T
111,S115,T119
a
Total number of moles of GalNAc incorporated after 1 h (figure before slash) or after 24 h (terminal reactions; figure after slash) as described under
Materials and methods.
b
Acceptor sites identified for human GalNAc-T2 in exhaustive/terminal reactions, with numbers indicating positions in the corresponding acceptor
peptide. Identification of the acceptor sites were performed with Edman degradation.
Fig. 6. Binding of HSV-1gC-1(114K,117R)A or HSV-1Rescue to different types of cells. The attachment assay was performed by adding the indicated amounts
of radiolabeled virus to monolayers of GMK AHl, Gro2C cells, sog9 EXT-1 cells, and L cells, respectively. All virus preparations used for
experimentation were derived from HSV-1gC-1(114K,117R)A- or HSV-1Rescue-infected GMK cells. Mean values and SEMs (n 3) are indicated.
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HSV-1Rescue for the two highest virus concentrations. These
results, which were reproducible in three complete, conse-
cutive triplicate experiments ( p5 0.005, n 9), would indi-
cate that the two basic amino acids at positions 114 and 117
are necessary for full binding capacity of HSV-1 to chon-
droitin sulfate but not to heparan sulfate. Attempts to use
peptide attachment blocking experiments failed to assign
any direct role of K114 and R117 in binding to cell surface
glycosaminoglycans; only small inhibitory effects (20%)
were achieved using a blocking peptide concentration of
50 mM and in fact the mutant peptide was a better inhibitor
of wild type as well as mutant virus than the wild-type
peptide (data not shown).
We also investigated whether the mutations induced
affected the plaque morphology of infected GMK, L cells,
and Gro2C cells (Figure 7), because this is a phenomenon
largely related to late functions of HSV-1 glycoproteins in
the infectious cycle (reviewed by Johnson and Huber, 2002;
Rajcani and Vojvodova, 1998). We found that the plaques
generated by HSV-1gC-1(114K,117R)A were almost 50% smal-
ler than those formed by HSV-1Rescue ( p5 0.001). The dif-
ference in plaque size between HSV-1gC-1(114K,117R)A and
HSV-1Rescue was observed for GMK and L cells as well as
Gro2C cells. This similarity between the three cell types was
in contrast to the finding that the different attachment rate
between mutant and wild-type virus was evident for only
one of the investigated cells, Gro2C. This supports the
notion that the changed plaque morphology on one hand
and attachment rate to Gro2C on the other hand each are
caused by different and independent consequences of the
altered O-linked glycosylation signal. It is important that
although the parental gC-1 null virus strain, designated
gC-39, produced syncytial plaques (syncytial and nonsyn-
cytial morphology depicted in Figure 8), we found that
neither the plaques induced by HSV-1gC-1(114K,117R)A nor by
HSV-1Rescue were syncytial, suggesting that no alterations
in the membrane fusion capacity of HSV-1 glycoprotein
were involved in the plaque size transition between these
two latter virus strains. As an extra control, we analyzed
confluent plates with more than 200 plaques each of
HSV-1gC-1(114K,117R)A and HSV-1Rescue using a gC-specific
monoclonal antibody. Interestingly, we found only a few
nonstained gC-1-negative revertant plaques from plates
infected with mutant as well as rescue virus, but as expected
these plaques were of the same syncytial, large phenotype as
the parent gC-1 negative virus strain. Altogether, the results
indicated that the O-glycosylation peptide signal also
affected viral spread in cell culture even in the absence of
cell surface heparan sulfate.
Discussion
The findings of this article are of significance at two levels.
First we have identified what seems to constitute labile
elements in an O-linked glycosylation signal of the highly
O-glycosylated protein gC-1. Thus, by changing two basic
amino acids of the glycosylation signal that were not targets
themselves for O-linked glycosylation, it was possible to
generate a mutant gC-1 equipped with a considerably higher
degree of O-linked glycosylation. In fact, the SDS±PAGE
mobility shift suggested a difference of more than 8000 Da
between mutant and wild-type gC-1, implying that the extra
content of O-linked glycans of mutant gC-1 could be as
much as 40 monosaccharide units. Although care should
be taken when calculating absolute masses for the carbohy-
drate complement of a glycoprotein from electrophoretic
data (Olofsson and Bolmstedt, 1998), our reported increase
in glycosylation is based on SDS±PAGE results from con-
tinuous as well as gradient polyacrylamide gels, represent-
ing two different principles, sieving and stacking,
respectively, for separation. Moreover, these systems have
demonstrated a good correlation between the calculated
carbohydrate content and electrophoretic mobility for
Fig. 7. (A) Plaque size of HSV-1gC-1(114K,117R)A and HSV-1Rescue in cultures of GMK and L and GMK cells. Virus preparations used for inoculation were
derived from GMK cells. The plaque size was read 4 days postinfection. (B) A separate comparison of the plaque sizes in GMK cells of mutant, rescue and
parental gC-null HSV-1 virus strain (gC-39). The plaque size was read 3 days postinfection. Mean values and SEMs (n 20) are indicated.
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mutant viral glycoproteins, lacking different numbers and
combinations of N-glycosylation sites (Bolmstedt et al.,
1991; Olofsson et al., 1999). Second, the peptide glycosyla-
tion signal harboring these two amino acids seems to influ-
ence two different processes in the HSV-1 life cycle: viral
binding to cell surface chondroitin sulfate and viral cell to
cell spread, at least as it is manifested in plaque morphology.
Thus the present wild-type gC-1 O-linked glycosylation
signal may be suboptimum for maximal O-linked glycosyla-
tion but optimum for maximal biological functionality.
The in vitro studies of O-linked glycosylation with indivi-
dual GalNAc-transferases, using synthetic peptides as sub-
strates, revealed some of the mechanistic details behind the
increased O-linked glycosylation of gC(114K,117R)A. We
choose GalNAc-T1, -T2, -T3, and -T6 because these are
enzymes that function with naked peptide substrates and do
not require prior GalNAc-glycosylation by other isoforms.
They also represent the best characterized isoforms both in
terms of specificity and expression patterns. GalNAc-T1
and -T2 further represent the most universally expressed
isoforms (for a review, see Hassan et al., 2000a). Of the
investigated GalNAc-transferases, only GalNAc-T2
demonstrated efficient activity with the wild-type and
mutant peptide substrates, but the mutant peptide sequence
was a significantly better substrate than the wild type.
Furthermore, amino acid sequencing and MALDI-TOF
MS showed that the mutant peptide was glycosylated with
three moles of GalNAc (T111, S113, and T119 ), whereas the
wild-type peptide was only glycosylated with two moles of
GalNAc (T119 and S113 ). Thus the presence of positively
charged amino acids among serine and threonine residues
in the wild-type gC-1 peptide is likely to direct a lower
density of O-glycosylation in this region, although the net
difference was only one additional GalNAc residue
attached with the mutant peptide.
It is clear that the total number of extra monosaccharides
of O-linked glycans of gC-1(114K,117R)A compared with wild-
type glycoprotein is considerably higher than what could be
harbored in one extra O-linked glycan of gC-1(114K,117R)A.
Considering that most of the O-linked glycans of gC-1,
produced in GMK cells, constitute structures up to tetra-
or possibly pentasaccharides (LundstroÈm et al., 1987a), it
appears unlikely that the contribution one or possibly two
new O-linked glycans of gC-1(114K,117R)A, as suggested from
the peptide model study, is sufficiently large to accommod-
ate that many monosaccharides. Hence our results suggest
that the induced mutations also affected the O-linked gly-
cans of regions outside the peptide range (residues 106 and
124), most likely the domain delimited by amino acids 40
and 100, where numerous clustered O-linked glycans are
harbored (Biller et al., 2000; Olofsson, 1992). This notion
is in several ways in accordance with our current view of the
temporal regulation of O-linked glycosylation. First, some
GalNAc-transferase isoforms are not able to add GalNAc
to a serine or threonine unless an adjacent serine or threo-
nine residue is preglycosylated (Bennett et al., 1998). Thus it
is possible that the facilitated addition of the first few
GalNAc residues in the mutated gC-1 may pave the way
for subsequently acting GalNAc-transferases, resulting in
further increase in O-glycan density of gC-1 outside the
peptide substrate sequence studied in this report. GalNAc-
transferases further contain lectin domains with specificity
for GalNAc-glycopeptides (Hassan et al., 2000b), and these
are involved in enhancing the O-glycosylation density and
possibly have other roles in directing O-glycosylation. Thus
a seemingly marginal improvement of the O-glycosylation
Fig. 8. Morphology of nonsyncytial HSV-1Rescue (A) and syncytial HSV-1 strain gC-39 plaques. Bar corresponds to 200 m. To improve visualization of
plaque fine structure, no immunostaining was applied.
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signal could have profound effects on the total content of
O-linked glycans in a glycoprotein, such as gC-1. The
notion that gC-1(114K,117R)A produced in cells with an intact
O-glycosylation machinery contains larger O-linked glycans
reflects a general increase in the size of each O-linked glycan
rather than an increased number of O-linked glycans is
supported by the comparison by the studies of gC-1Rescue
and gC-1(114K,117R)A, produced in C1300 cells, containing
only O-linked monosaccharides and to some extent
sialylated GalNAc (STn) (LundstroÈm et al., 1987b).
The induced modification of the O-glycosylation changed
the biological properties of HSV-1 in two ways. First, the
decrease in the ability of HSV-1 to bind to the surface of
chondroitin sulfate±expressing cells, which represents the
initial step in a series of interactions between HSV-1 and
different cellular receptors (Campadelli-Fiume et al., 2000;
MaÊrdberg et al., 2002). Second, the reduced size of the
mutant virus plaques, which represents altered viral cell-
to-cell spread, a more complex process as outlined in detail
later. The chondroitin sulfate± and heparan sulfate±binding
sites of gC-1 are largely overlapping, and several arginine
residues and a few hydrophobic amino acid residues in the
peptide stretch aa 129±160 are important determinants for
binding to both types of glycosaminoglycan (MaÊrdberg
et al., 2001, 2002; Trybala et al., 1994). Thus the increased
content of O-linked glycans in gC-1(114K,117R)A may inter-
fere either sterically or electrostatically with the interactions
between gC-1 and chondroitin sulfate. Therefore one func-
tion of K114 and R117 could be to maintain an optimum net
charge of a domain of significance for chondroitin sulfate
binding, achieved by negative modulation of O-glycan sia-
lylation, further supported by their cationic nature. Still, it is
possible that identical domains of gC-1 are involved in
chondroitin and heparan sulfate binding; the interference
by O-linked glycans may affect the access for each type of
glycosaminoglycan differently. Hence the dynamic respon-
siveness of this O-glycosylation signal may be a viral means
to moderate the level of gC±chondroitin sulfate interactions.
Regarding the other biological effects of the modified
O-linked glycosylation sequence, there is so far no specific
role for gC-1 defined in the processes determining plaque
size and viral cell-to-cell spread. The interplay between
different HSV-1 gene products in promoting cell-to-cell
spread is complex, involving several HSV-1 glycoproteins.
Thus gD-1 seems to be a key factor for cell-to-cell spread of
wild type HSV-1 strains in cultured cells (Cocchi et al.,
2000), whereas cell-to-cell spread in keratinocytes may be
mediated by gI/gE without any involvement of gD-1(Huber
et al., 2001; Johnson and Huber, 2002). Moreover, syncytial
mutants of HSV-1 may spread among cells owing to the
activity of gK-1, possibly supported by gC-1 (Pertel and
Spear, 1996). If the function of gC-1 is regulatory, it may be
difficult to assign a role to gC-1 in this multitude of inter-
actions by use of deletion mutants. In spite of this, the
present data suggest that the O-linked glycosylation signal
of gC-1 constitutes one of several factors affecting the pla-
que size of HSV-1, probably by one or more of at least three
conceivable ways. First, gC-1 interaction with cell surface
chondroitin but not heparan sulfate is essential for the large
plaque size phenotype of HSV-1. This explanation seems
unlikely, because of the small decrease in chondroitin
sulfate binding as observed for HSV-1gC-1(114K,117R)A com-
pared with wild-type virus (Figure 4). Second, the O-linked
glycans of gC-1 may modulate the cell-to-cell spread-
promoting of other HSV-1 glycoproteins, including, gE/gI,
gK, or gD. Third, the O-linked glycosylated peptide signal
with its O-glycan array may itself be engaged in cell-to-cell
spread or cell morphology activities affecting plaque size.
This latter hypothesis is in line with both findings that (1)
the degree of Ebola virus±induced cell detachment is pro-
portional to the length of a used O-linked glycosylation
signal in the Ebola virus glycoprotein (Simmons et al.,
2002), and (2) the finding that such signals are engaged
also on nonviral cell detachment mechanisms (Chervenak
and Illsley, 2000).
Materials and methods
Cells and viruses
GMK-AHI cells were grown in Eagle's minimum essential
medium (EMEM) supplemented with 4% heat-inactivated
fetal bovine serum and 0.05% Primaton RL substance. The
murine fibroblast cell line LMtk-, clone ID, and its HSV-
resistant variants gro2C, expressing chondroitin sulfate
only (Gruenheid et al., 1993), and sog9 EXT-1 cells, expres-
sing heparan sulfate but no other glycosaminoglycan mar-
ker (McCormick et al. 1998), were grown in Dulbecco
modified Eagle's medium (DMEM) supplemented with
10% fetal bovine serum in 5% CO2 atmosphere. The
mouse neuroblastoma cell line was propagated as pre-
viously described (LundstroÈm et al., 1987b).
The mutated HSV strain HSV-1gC-1(114K,117R)A has two
amino residue substitutions, specifically lysine and arginine
residues at positions 114 and 117 replaced with alanine
residues. The HSV-1 virus designated HSV-1Rescue was
used as a wild-type control, and this virus expresses an
unmodified gC gene introduced into the HSV-1 gC null
strain gC-39 (Holland et al., 1984). HSV-1gC-1(114K,117R)A
and HSV-1Rescue were originally constructed for studies on
the heparin sulfate±binding site of gC-1, and both viruses
have been characterized in detail previously (MaÊrdberg
et al., 2001). To avoid possible differences in other genes
than gC-1, the wild-type and the mutated gC-1 genes were
inserted into gC-39 using identical protocols for homol-
ogous recombination to produce infectious virus clones.
Three plaques each of mutant and wild-type virus were
selected for further experimentation and the entire gene
for gC-1 was control sequenced (MaÊrdberg et al., 2001).
The gC-1-null strain gC-39 produced essentially syncytial
plaques, whereas the plaques of HSV-1gC-1(114K,117R)A and
HSV-1Rescue were nonsyncytial. The number of physical
viral particles was calculated as previously described
(MaÊrdberg et al., 2001). The virus particle/PFU ratio varied
between 500±1000, with no significant difference between
mutant and rescue virus. The term gC(K114, R117)A is used for
designation of the mutant gC-1 protein.
In vitro assessment of O-glycosylation capacity
Polypeptide GalNAc-transferase assays were carried out
essentially as described using soluble, secreted, purified
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recombinant human GalNAc-T1, -T2, -T3, and -T6,
expressed in insect cells (Bennett et al., 1996; Wandall
et al., 1997). Acceptor peptides, representing rescue
gC-1, 106PKNNTTPAKSGRPTKPPGP124, and gC(K114,
R117)A, 106PKNNTTPAASGAPTKPPGP124, were syn-
thesized by Chiron Mimotopes (Victoria, Australia), and
purified by the manufacturer to 99% purity. Briefly, the
assays were performed in 25 ml total reaction mixture
containing 25 mM cacodylate (pH 7.4), 10 mM MnCl2,
0.25% Triton X-100, 200 mM UDP- [14C]-GalNAc
(3,700 cpm/nmol) (Amersham Pharmacia Biotech AB,
Uppsala, Sweden) or 2000 mM UDP-GalNAc, 15 mg accep-
tor peptide for assays with GalNAc-T1, -T2 and -T3 and 0.78
to 25 mg acceptor peptide for assays with GalNAc-T6, and
0.25 mU of each purified GalNAc-transferase, respectively.
Soluble, secreted forms of the human GalNAc-transferases
analyzed were expressed in High Five cells, grown in cell-free
media, and purified to near homogeneity with specific activ-
ities of 0.6 U/mg for GalNAc-T1, 0.5 U/mg for GalNAc-T2,
0.5 U/mg for GalNAc-T3, and 2.35 U/mg for GalNAc-T6
measured using peptides derived from MUC2, MUC1,
and MUC7 human mucin tandem repeats as described
previously (Wandall et al., 1997). Products were quantified
by liquid scintillation counting after chromatography on
Dowex-1, octadecyl silica cartridges (Mallinkrodt Baker
Inc, Philipsburgh, NJ), or HPLC (PC3.2/3 or mRPC C2/
C18 SC2.1/10 Pharmacia, Smart System; Amersham
Pharmacia).
Evaluation of GalNAc incorporation into peptides was
performed by MALDI-TOF mass spectrometry (Voyager
DE; AME Bioscience, Toroed, Norway) as described pre-
viously (Schwientek et al., 2002). Sites of incorporation was
analysed by Edman degradation on an Applied Biosystems
Procise HT 494 sequencer using glass fiber filters precycled
with BioBrene Plus (Applied Biosystems, Foster City, CA)
as immobilizing support. (N-terminal sequence analysis was
carried out at the Protein Analysis Center, Kardinska Insti-
tute, Stockholm, Sweden.) The peptide samples were aliquots
of HPLC fractions isolated in a mixture of acetonitrile, 0.1%
trifluoroacetic acid and water. The samples were spotted
onto the BioBrene Plus treated and precycled glass fiber
filters. The PTH derivatives were separated on-line using a
Brownlee Spheri-5PTH, 5 micron, 220 2.1 mm C18 col-
umn at 0.325 ml/min. N-terminal sequence analysis was
carried out using a Procise HT instrument (Applied Bio-
systems) after application of samples in solution to precycled
Biobrene-treated glass fiber filters (Applied Biosystems).
Metabolic labeling and immunoprecipitation of HSV-1
glycoproteins
Confluent layers of GMK cells in 6-well culture plates were
washed two times with serum-free EMEM and infected with
HSV-1Rescue or HSV-1gC-1(114K,117R)A at a m.o.i. of 3. The
virus was allowed to adsorb to the cells for 1 h at 37C,
followedbyaddition ofEMEM, containing antibiotics. After
incubation in CO2-incubator for 4 hours 50 mCi/ml D-[6-
3H]-
glucosamine hydrochloride ([3H]-GlcN; Amersham
Pharmacia, 30 Ci/mmol) was added. The cells were radio-
labelled for 20 hours until harvest. The labeled culture
supernatant was removed from cells and supplemented
with 1% (v/v) NP40 and 1 mM AEBSF (4-(2-aminoethyl)-
benzenesulfonyl, HCL:p-aminoethylbenzenesulfonyl fluo-
ride, HCl; Calbiochem/Novabiochem, San Diego CA). Cells
were detached using rubber policemen, washed twice with
TBS (tris-buffered saline; 150 mM NaCl, 50 mM tris HCL,
pH 7.5) and resuspended in 1 ml TBS containing, 1 % (v/v)
NP40 and 1 mM AEBSF. Cell suspensions were sonicated on
ice followed by centrifugation to remove cell debris.
Radioimmunoprecipitation was carried out essentially
as previously described (LundstroÈm et al., 1987a). Heat-
inactivated formalin-fixed S. aureus, coated with anti-
mouse antibodies (Dakopatts, Glostrup, Denmark), were
mixed with anti-HSV-1gC-specific mouse monoclonal anti-
bodies B1C1 or C4H11B for 2 hours at 4C (Olofsson et al.,
1983; SjoÈblom et al., 1992). The antibody-staphylococcus
complex was then washed three times in TTB [(TBS, con-
taining 1% Triton X-100 and 0.1% bovine serum albumin
(BSA)] and mixed with labeled culture supernatants or
labeled cell lysates overnight at 4C. The samples were
washed twice in TTB and twice in TBS prior to analysis
by homogenous SDS-PAGE (9.25% polyacrylamide gels)
or gradient gel SDS-PAGE (NuPAGE 4-12%; Invitrogen;
Carlsbad, CA) and fluorography (Amersham Pharmacia).
In some experiments gC-1 was detected by immunoblot,
using a monoclonal antibody specific for a linear epitope
(SjoÈblom et al. 1992).
In some experiments radiolabeled gC-1 was affinity-
purified as previously described and subjected to sialidase
(V. cholerae, Behringwerke, Marburg, Germany; 100 U/ml)
treatment at pH 4.5 for 2 h at 37C. The glycoprotein and
the released sialic acid were separated by gel filtration on
short disposable Sephadex G-25 columns (Amersham
Pharmacia).
N-Glycosidase (N-glycanase) digestion of
immunoprecipitated glycoproteins
The enzymatic elimination of N-linked glycans was per-
formed essentially as previously described (Olofsson et al.,
1999). Briefly, [3H]-GlcN-labeled culture supernatants were
immunoprecipitated as described above but after final wash
the samples were resuspended in 10 ml 20 mM sodium
phosphate buffer pH 7.5, containing 10 mM EDTA,
0,005% sodium azide, 1% (v/v) b-mercaptoethanol, 1%
(w/v) sodium dodecyl sulphonate (SDS) and incubated for
20 minutes at 37C. The glycoprotein was denatured and
eluted from the Staphylococci by boiling for 5 minutes
followed by centrifugation. The samples were then diluted
10 times in 20 mM sodium phosphate buffer pH 7.5 con-
taining, 10 mM EDTA, 10 mM sodium azide, 1% (v/v)
b-mercaptoethanol, 2% (v/v) NP40 to avoid SDS denatura-
tion of PnGase. PnGase (6 ml of 200IU/ml; Roche Applied
Sciences, Stockholm) was added to samples prior to incuba-
tion at 37C for 20 hours. After acetone precipitation
samples were finally analyzed on SDS-PAGE and auto-
radiography (Amersham Pharmacia).
Purification of extracellular virus
The purification of radiolabeled HSV-1 rescue and mutant
strains were performed as previously described (MaÊrdberg
et al., 2001). In brief, roller bottle cultures of GMK-AH1
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cells were infected with either virus strain. Following virus
adsorption the cells were washed, and 45 ml fresh EMEM
supplemented with 40 mC/ml of [methyl-3H]- thymidine
(25 Ci per mmol, Amersham) was added. The cells were
incubated for further 48 h, and thereafter the virus was
pelleted from culture medium and purified using a tree-
step discontinuous gradient of sucrose as described (Karger
et al., 1995). Unless otherwise stated, purified virus was
resuspended in PBS containing 0.1% BSA and stored at
ÿ70C. The numbers of virus particles in the purified pre-
parations were calculated based on the determination of the
DNA content (Karger et al., 1995).
Binding of radiolabeled virus to cells
Monolayers of GMK AHl, Gro2C cells, sog9 EXT-1 cells
and L cells in 96-well plates were precooled for 30 min at
4C, then washed twice with cold PBS and blocked for 1 h at
4C with PBS-BSA. Different virus strains, adjusted to
contain the same initial number of viral particles, were
serially diluted in PBS-BSA, as indicated in the figure
legends. Equal 50-ml portions of each virus dilution were
added in triplicate, and the plates were left for virus adsorp-
tion for 5 h at 4C under continuous agitation. Subse-
quently, the cells were washed three times in cold PBS to
eliminate unadsorbed virions and lysed in 5% SDS. The
radioactivity was determined by scintillation counting, and
the results were expressed as the percentage of attached
virions relative the number of virus particles originally
added to the cells.
Virus plaque size assay on glycosaminoglycan-deficient cells
Monolayers of GMK-AHl and L cells in 6 well plates were
infected with about 200 pfu per strain of the mutated HSV,
gC(114K,117R)A, as well as the rescue strain (HSV-1Rescue).
The monolayers were washed in complete medium, DMEM
high glucose (L cells) and EMEM (GMK AHl) supple-
mented with penicillin and streptomycin prior to virus addi-
tion. The virions were allowed to adsorb at 37C for 2 h,
and thereafter the cells were washed three times in complete
medium, and 1% methylcellulose solution was added. The
cells were incubated for 3 or 4 days, as indicated in figure
legends, and nonconfluent plaques were detected by black
plaque assay with the gC-1-specific MAB B1C1 (Nilheden
et al., 1983; Olofsson et al., 1983). The plaque size was
determined essentially as described by Baigent et al.
(2001). In brief, the plates were photographed together
with a ruler, using a computer-assisted CCD camera, and
the largest diameter of each plaque was determined at 3
magnification, using the ruler scale for standardization. A
mean value was calculated for each strain and cell line, and
the statistical significance of the measurements was deter-
mined by using Student t-test.
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Abstract
Herpes simplex virus type 1 (HSV-1) induces prominent shifts in the rates of transcription of host cellular genes of relevance for the
outcome of the viral infection. The quantitative analysis of transcription may be obscured by virus-induced alterations in the levels of RNA
encoded by cellular housekeeping genes that are used commonly for normalisation of real time reverse transcription PCR (RT-qPCR). In the
present study, we analysed -actin, GAPDH and 18S rRNA for their usefulness in normalisation of RT-qPCR analysis of the transcription
of the HSV-1 gamma gB-1 gene and FUT5, a cellular gene induced by viral infection. The transcription of these genes was monitored in a
TaqMan-based real time RT-PCR system over a 24 h interval of virus infection of human embryonic lung fibroblasts. The levels of gB-1 and
FUT5 RNA were normalised via difference in the threshold cycle (Ct) values relative to each and one of the housekeeping genes or calculated
in relation to the number of infected cells without any further normalisation. The levels of RNA encoded by -actin or GAPDH were found
to vary by several orders of magnitude during HSV-1 infection, introducing large errors in the estimation of the gB-1 and FUT5 RNA levels.
In contrast, the variation of Ct values for 18S rRNA was less than one cycle during 24 h period of HSV-1 infection. The FUT5 and gB-1 RNA
figures obtained by Ct normalisation relative 18S rRNA were identical to those calculated in relation to the number of infected cells. These
data recommend 18S rRNA for normalisation in HSV-1-infected human cells but discourage the use of -actin and GAPDH RNA for this
purpose. By applying these procedures, it was shown that the transcription of FUT5 was increased by 50-fold 5–24 h after HSV-1 infection
and 200-fold by the inhibition of viral DNA replication in HSV-infected cells.
© 2004 Elsevier B.V. All rights reserved.
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1. Introduction
The infection of a cell by the herpes simplex virus type
1 (HSV-1) and other members of the herpesvirus family
is often associated with prominent changes in the execu-
tion of the host cellular transcription program. During the
lytic phase, HSV-1 infection such changes were considered
to reflect an almost general virus-induced shut-down of the
host cell-specific macromolecular synthesis (Spencer et al.,
1997), but recent data demonstrate maintained or even in-
creased rates in transcription of several cellular genes after
HSV-1 infection (Taddeo et al., 2002). The virus-induced
changes in the cellular transcription programme may also be
∗ Corresponding author. Tel.: +46-31-342-46-59;
mobile: +46-705-60-46-59; fax: +46-31-82-70-32.
E-mail address: sigvard.olofsson@microbio.gu.se (S. Olofsson).
more subtle and probably constitute parts of the herpesvirus
strategy of establishing lifelong persistent infections in hu-
mans, with periods of latency and occasional episodes of
recurrencies. In some cases, cellular genes whose transcrip-
tion is a target for viral modulation are involved in adap-
tive and acquired immune mechanisms, and recently it was
shown that virus-induced transcriptional changes in host cell
glycosylation could be involved in such strategies. Thus, cy-
tomegalovirus affects the transcriptional program of three
glycosyl transferase genes involved in the formation of sialyl
Lewis X, a carbohydrate determinant serving as a receptor
for selectins, which are active in the homing of neutrophiles
(Cebulla et al., 2000; Vestweber and Blanks, 1999).
In this context, the gene product encoded by FUT5 is
relevant (Weston et al., 1992) and might be important to
the HSV-1 infection. This enzyme constitutes an 3/4-
fucosyltransferase, engaged in formation of cell surface
0166-0934/$ – see front matter © 2004 Elsevier B.V. All rights reserved.
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complex carbohydrates, but whose regulation of expression
in different tissues or biological importance is not known
(Cameron et al., 1995). However, pilot experiments sug-
gested that HSV-1 infection could awake expression of
FUT5 during the infectious cycle, and therefore, FUT5 was
chosen as a model for cellular genes that are inducible by
the virus infection.
Studies on how the virus regulates the expression of host
cellular genes may reveal important features of the inter-
play between a herpesvirus and its host. The advent of real
time PCR (qPCR) has facilitated such studies because older,
cumbersome, and at most, semiquantitative techniques such
as Northern blot have been replaced by accurate, sensitive
and rapid real time RT-PCR-based procedures (RT-qPCR).
RT-qPCR has a capacity to quantitate the transcription rates
with a dynamic range of several orders of magnitude. How-
ever, the success of this approach is dependent on the use
of housekeeping genes as internal standards for defining a
background rate of transcription for normalisation of the
analysis of a particular target gene. Examples of such house-
keeping genes with presumed constant rates of transcription,
independent of differences in cellular metabolic activity are
-actin, GAPDH, and 18S rRNA. Not surprisingly, there are
types of experimental situations where manipulation of the
cellular status considerably may affect the rate of transcrip-
tion also of housekeeping genes (Weisinger et al., 1999).
Hence, it can probably not be anticipated that the profound
change in the cellular metabolism posed by a virus infection
is compatible with maintenance of a constant transcription
rate of all housekeeping genes, used for normalising tran-
scriptional analysis, by RT-qPCR. In other words, if varia-
tions in transcription rates of classical housekeeping genes
vary during normal cell development they may be expected
to be much worse during virus replication of an infected cell.
The expression of some frequently used housekeeping
genes was compared during herpes simplex virus type 1 in-
fection of diploid cells, and it was determined whether they
could be used for normalisation in analysis of transcriptional
regulation of viral genes as well as of “non-housekeeping”
genes in the infected cells. The results indicate that a careful
choice of a suitable housekeeping gene, based on practical
experimentation (Thellin et al., 1999), is necessary for a re-
liable transcriptional analysis of a virus-infected cells, using
real time PCR. However, provided that such measures have
been taken it is possible to find suitable housekeeping genes
for transcriptional studies even in cells infected with herpes
simplex virus, which has been considered to shut-off most
cellular genes.
2. Materials and methods
2.1. Cells and virus infection procedures
Human diploid embryonic lung fibroblasts (HEL cells) of
low passage number were used throughout the study (2%
fetal calf serum during cell growth). Cell cultures in 6-well
tissue culture plates (750,000 cells per well; serum deple-
tion) were infected with 12 plaque forming units (PFU) per
cell of the laboratory prototype HSV-1 strain Syn 17+. The
virus was allowed to bind for 1 h and cultures infected in par-
allel were harvested at 40 min, 1, 3, 5, 7, 9, and 24 h, respec-
tively. In some experiments indicated in the figure legends,
HSV-1 DNA replication was inhibited, using 80M acy-
clovir (GlaxoSmithKline, Stockholm). Virus-infected and
parallel non-infected cells were harvested by trypsination
(0.4% trypsin in phosphate-buffered saline) and centrifuged
at 260 × g for 6 min. The cells were washed before lysis
(RNA isolation kit II, Roche Diagnostics Scandinavia AB).
The lysed cells were processed for total RNA extraction as
described below.
Green monkey kidney AH-1 (GMK) cells (Günalp, 1965)
were used for plaque titration.
2.2. RNA extraction
The MagNA Pure LC Isolation station (Roche Diagnostics
Scandinavia AB, Stockholm) was used for the isolation of
total RNA from the lysed cells. Briefly, 200l of the lysed
cells were isolated in duplicate using the RNA isolation kit
II (for cultured cells) (Roche Diagnostics Scandinavia AB)
exactly as described by the manufacturer. Total RNA was
eluted in a final volume of 100l. The purity of the RNA
preparations was checked by the 260 nm/280 nm ratio (range
1.8± 0.2).
2.3. Total nucleic acid extraction for HSV-1 DNA analysis
For quantitation of progeny HSV-1 DNA the MagNA Pure
LC Isolation station was used as described by the manu-
facturer, applying the total nucleic acid isolation kit (Roche
Diagnostics Scandinavia AB, Stockholm). Control experi-
ments revealed that there was no remaining RT activity of
the Taq that could result in disturbing amplification of possi-
ble gB-1 RNA contamination in the samples used for HSV-1
quantification (see Section 2.4).
2.4. Real time PCR
Primers and probes (sequences of the primers and probes
are listed in Table 1) were designed according to the
guidelines of Applied Biosystems with help of the Primer
Express 2.0 software (Applied Biosystems). Primers were
custom synthesised by Thermo Electron Corporation (Ulm,
Germany). The RNA analysis was undertaken using the Taq-
Man One-Step RT-PCR Master Mix reagents kit (Applied
Biosystems) and 40 ng of total RNA. The reverse transcrip-
tion reaction was run at 48 ◦C for 30 min and the following
PCR according to the manufacturer’s instructions, for 40 cy-
cles (95 ◦C 15 s, 60 ◦C 60 s) using 2× AmpliTaq Gold DNA
Polymerase mix, 40× RT enzyme mix, forward and reverse
primers (0.5M) and probe (0.3M). All one-step PCR
K
.Nyström
et
al./Jo
u
rn
al
ofVirologicalM
ethods118(2004)83–94
85
Table 1
TaqMan real time PCR systems used in the present study
Gene Ass number Forward primer Reverse primer Probea Comments
18S rRNAb RT-PCR.
-Actin NM 001101 CCCAGCCATGTACGTTGCTA TCACCGGAGTCCATCACGAT ACGCCTCTGGCCGTACCACTGG RT-PCR method: the present paper.
GAPDH NM 002046 GAGAAGGCTGGGGCTCAT TGCTGATGATCTTGAGGCTG CTCTGCTGATGCCCCCATGTTCGT RT-PCR method: the present paper.
gB-1 AF259899 TTTGTGTACATGTCCCCGTTTTAC AGAAGCCGTCGACCTGCTT ACACCGAACACACCAGCTACGCCG RT-PCR method: the present paper.
FUT5 NM 002034 CGCTGGATCTGGTTCAGC AT CAGCCGTAGGGCGTGAAG CCCCCAGCAACTGCCGGC RT-PCR method: the present paper.
gB-1 AF259899 GCAGTTTACGTACAACCACATACAGC AGCTTGCGGGCCTCGTT CGGCCCAACATATCGTTGACATGGC Direct PCR; for the estimation of HSV-1
genome copy number. Method: Lindh
et al. (manuscript in preparation).
a All probes, except for the commerical 18S rRNA system, were fluorescently labelled with FAM in 5′ and TAMRA in 3′ position. The molarities of the constituents of the reaction mixtures are
given in Section 2.
b Commercial pre-developed TaqMan AssayTM (Applied Biosystems). primer and probe sequences not public.
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reactions were performed in 30l reaction volumes, and
carried out in a 96-well plates, which was centrifuged for
1 min at 1000× g at room temperature in a swing-out rotor
(Rotina 48R; Hettich, Tuttlingen, Germany) to remove small
air bubbles in the reaction vessels. The amplification and
detection was carried out with an ABI Prism 7000 sequence
detection system (Applied Biosystems). The Ct value was
defined as the number of PCR cycles required for the flu-
orescence signal to exceed the threshold value (defined as
10 times the standard deviation of the baseline variation).
Ct values were defined as the absolute value of the dif-
ference between the Ci of the target RNA (gB-1 or FUT5)
and the housekeeping gene RNA Ct value for each sam-
ple (Hamalainen et al., 2001), and approved only when the
slope of the standard curve for the target gene was paral-
lel with the standard curve for the housekeeping gene RNA
(slope difference less than 0.1). The standards used (except
for 18S rRNA) were plasmids created with Topo TA (In-
vitrogen AB, Stockholm) according to the manufacturer’s
instructions. The plasmids were used in 10-fold dilutions in
the real time PCR in question and the reaction was carried
out as described above. To facilitate comparisons, the rela-
tive concentration, CR, of gB-1 or FUT5 RNA were calcu-
lated using the formula CR = 2C−Ct , where C is the Ct
value for the lowest RNA concentration detectable for each
target gene.
The HSV-1 gB-1 DNA qPCR was carried out in the same
manner as the real time RT-PCR reaction but instead us-
ing 2× TaqMan Universal Master Mix (containing uracil
N-glycolase; Applied Biosystems), forward primer, reverse
primer (0.9M of each) TaqMan probe (0.2M), and 20l
of isolated DNA. Cycling temperatures were the same as
those in the one-step RT-PCR.
Fig. 1. Time course of HSV-1 production in infected cells. The line graphs show the number of HSV-1 genome equivalents (measured with gB-1 as
the target gene) per 20l cell extract. Symbols and bars denote mean and standard deviations (n = 3), respectively. The open and the filled bars show
number of PFU/ml at 24 h post-infection for non-treated and acyclovir-treated cells, respectively.
2.5. HSV-1 plaque titration
Monolayers GMK cells in 6-well plates were infected
with 10-fold dilutions of media from infected cells at 5 h or
24 h post-infection, respectively. The virions were allowed
to adsorb at 37 ◦C for 1 h, and thereafter, 1% methylcellulose
solution was added. The cells were incubated for 3 days
and plaques were detected after ethanol fixation and staining
with Alcian Blue.
3. Results
3.1. Expression of the HSV-1 γ-gene gB-1
The HSV-1 gene encoding glycoprotein gB-1, which is
transcribed a little before but abundantly after viral DNA
replication (Roizman and Knipe, 2001) was chosen as a
probe for monitoring virus-specific transcription. To deter-
mine the influence of DNA replication on the gB-1 expres-
sion virus infected cells were examined both in the presence
or absence of inhibiting concentrations of acyclovir. First,
the acyclovir effect on viral replication was analysed by as-
saying: (i) the reduction of progeny viral genome copies by
qPCR in the DNA format and (ii) the reduction of viable
progeny virus by plaque titration (Fig. 1). Prominent HSV-1
DNA replication could be detected as early as 5 h p.i. in
the absence of acyclovir and the number of HSV-1 genome
copies increased continuously during the incubation period.
In the presence of acyclovir the DNA replication was less
than 1% of that recorded from untreated, infected cells, and
accordingly, acyclovir treatment decreased the virus infec-
tivity by more than two orders of magnitude (Fig. 1). These
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Fig. 2. Determination of gB-1 RNA expression in HSV-1-infected cells, using RT-real time PCR. Panel A shows the Ct values and panel B shows the
relative concentration (CR) of RNA calculated from the formula: CR = 2C−Ct , where C is a constant, which is assigned a value of near 1, for the
lowest RNA concentration detected for the results of each panel, respectively.
data indicate that the acyclovir treatment abrogated DNA
replication during the current experimental conditions.
The first sign of gB-1 transcription, reproducible although
small and hardly discernable in the graph (Fig. 2), was
obtained at 1 h post-infection and the kinetic graphs were
similar for virus-infected cells propagated in the absence or
presence of acyclovir at least up to 3 h of post-infection. To
enable more accurate comparisons of the transcription rate
the Ct values, representing the RNA concentrations in a
logarithmic manner, were transformed into a linear format
(Fig. 2, panel B). This procedure revealed prominent, but ex-
pected differences in the transcription rate of the gB-1 gene
between acyclovir-treated and untreated cells. Thus, from
5 h post-infection and onwards, the RNA levels remained
relatively constant for the acyclovir-treated cells, although
a decline was detected at 24 h post-infection. In contrast,
in the absence of acyclovir the level of gB-1-specific RNA
from the infected cells was increased by several 100-fold,
compared with the 1 h post-infection value. In spite of a
small decrease at 9 h, a high gB-1 RNA concentration was
also recorded at 24 h post-infection. The dramatic increase
in gB-1 gene transcription coincided with the occurrence
of more massive viral progeny DNA replication at 5 h
post-infection. Most likely, the vast majority of gB-1 RNA
originated from transcription of progeny HSV-1 DNA in
the cells propagated without acyclovir. In acyclovir-induced
absence of DNA replication the gB-1 transcription declined
over time with only low levels detectable at 24 h. Altogether
the results confirmed that the transcriptional machinery of
HSV-1-infected cells remained intact at least up to 24 h
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Fig. 3. Determination of housekeeping gene RNA expression in HSV-1-infected cells, using RT-real time PCR. The identity of the target genes is
indicated in the lower right corner of each panel.
post-infection in spite of the cytopathic effects induced by
the high virus inoculum used for infection.
3.2. Expression of classical housekeeping genes in
HSV-1-infected cells
The same RNA extracts were also used to explore the fea-
sibility of three housekeeping genes used commonly as in-
ternal standards in transcriptional analysis of herpes-infected
cells. The recorded Ct values for expression of the human
genes encoding GAPDH, -actin and 18S rRNA are shown
in Fig. 3. RNA originating from all three genes were readily
detected in HSV-infected as well as non-infected cells with
Ct-values ranging from 18 to 26, indicating the assay sen-
sitivity did not pose a hurdle for use of any of these genes.
However, the Ct values for GAPDH and -actin varied to
some extent not only dependent on the infection status of
the cells but also dependent on length of the observation
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Fig. 4. Relative concentrations of housekeeping gene RNA in HSV-
infected cells. The relative concentrations were calculated with the same
formula as in Fig. 2. The ordinate scale is identical for the three panes
in order to illustrate the differences in specific RNA variation between
the three target genes. Inset in the 18S rRNA pane shows identical data
but using an expanded Y scale.
period. To explore further, this phenomenon the Ct data
were transformed into RNA concentration linear representa-
tions (Fig. 4). The results were also normalised to facilitate
comparison of the concentrations between non-infected
cells and HSV-infected cells in the presence or absence of
acyclovir, respectively, for each of the housekeeping genes.
However, only results within the same panel are compara-
ble in terms of concentrations. These results demonstrated
that GAPDH RNA concentrations varied more than one
order of magnitude dependent on whether the cells were
infected or not or dependent on the length of the incubation
time. Even worse, the -actin RNA concentrations varied
more than two orders of magnitude. In contrast, the tran-
scription rates of 18S rRNA were very similar for infected
and non-infected cells over the time interval observed. The
inset at the bottom panel of Fig. 4 shows the 18S rRNA
variation at a higher scale, demonstrating no significant
difference in the rate of transcription except for the decline
for non-infected cells at 24 h post-infection.
3.3. Feasibility of classical housekeeping genes for
normalisation of transcription in HSV-1-infected cells
The Ct values for gB-1 RNA expression relative each
of the three housekeeping genes from corresponding gB-1
RNA Ct value were calculated (Fig. 5). There were sev-
eral similarities between the three panels although the span
between the largest and the smallest gB-1 Ct value was
more prominent for the -actin and GAPDH normalisation
than corresponding span for the 18S rRNA normalisation.
The great impact of these relative small differences in terms
of logarithmic values became evident after transforming the
Ct values to linear relative concentration representations
(Fig. 6). Thus, almost absurd overestimates of the rate of
gB-1 transcription were found in the linear perspective, using
-actin (more than a 100,000-fold increase) and GAPDH (a
20,000-fold) for normalisation, reflecting the effects of the
prominent decline in -actin and GAPDH expression over
time in HSV-infected cells. In contrast, the use of 18S rRNA
for normalisation resulted in gB-1 RNA expression graphs
congruent with those obtained in Fig. 2B, where the relative
RNA concentration determinations were calculated versus
a fixed concentration of total RNA. In conclusion, the 18S
rRNA gene but neither the -actin nor the GAPDH gene
appears relevant for normalisation in transcriptional studies
on HSV-1-infected human fibroblasts.
3.4. Application of the 18S rRNA gene for normalisation
of FUT5 gene expression HSV-1-infected cells
Preliminary experiments showed that transcription of cel-
lular FUT5 was increased by HSV-1 infection of permissive
cells, and FUT5 was therefore chosen as a model for cellular
genes that are inducible by the virus infection. In the next
series of experiments, we evaluated whether it was possible
to use 18S rRNA for normalisation of results obtained from
RT-qPCR analysis of FUT5 transcription. Thus, the levels of
FUT5 RNA were determined, using RNA extracts from the
same HSV-1-infected cells as in the experiments described
above. The relative concentration data, calculated from the
actual Ct values are presented in Fig. 7.
It was found that the expression of FUT5 RNA was low
and constant in non-infected cells over time, whereas HSV-1
infection induced an almost 100-fold increase in expression
of FUT5 RNA. Acyclovir treatment of infected cells resulted
in a further pronounced enhancement of the of FUT5 RNA
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Fig. 5. Expression of the gB-1 RNA concentrations in terms of Ct values relative to RNA concentration of each of the three housekeeping genes.
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Fig. 6. Linearized gB-1 RNA concentrations calculated from the Ct values of Fig. 5, using the formula indicated in Fig. 2.
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Fig. 7. Linearized FUT5 RNA concentrations in HSV-1-infected cells expressed per 100,000 infected cells, normalised relative 18S rRNA, using the
formula indicated in Fig. 2.
expression in HSV-1-infected cells, i.e. 250-fold compared
with the expression in non-infected cells. The slightly earlier
appearance of FUT5 RNA in HSV-1-infected cells in the
absence of acyclovir was reproducible although different
batches of cells were used in different experiments.
Finally, control experiments were undertaken to ensure
that the FUT5/18S rRNA Ct values recorded were consis-
tent and not variable due to differences in the number of cells
used for extraction of RNA (Fig. 8). Non-infected cells (low
Fig. 8. Cell concentration dependence of FUT5/18S rRNA Ct values. RNA preparations from different numbers of non-infected cells (filled circles)
and HSV-1-infected cells, harvested at 7 h post-infection (open circles), were analysed for FUT5 RNA and 18S rRNA in RT-qPCR. The Ct values
were calculated as described in Section 2. The lowest cell density analysed in the graph corresponded to that used in Figs. 2–7 above.
levels of FUT5 RNA expected) and HSV-1-infected cells,
harvested at 7 h post-infection (high levels of FUT5 RNA
expected), were chosen for these experiments, and RNA, pu-
rified from cells of each density were assayed for the 18S
rRNA and FUT5 Ct values, respectively. It was found that
the Ct values calculated for FUT5 from HSV-1-infected
cells were approximately 3 with no significant variation be-
tween the three RNA concentrations analysed. Correspond-
ing values for non-infected cells were approximately 8, but
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the S.D. recorded for lowest cell concentration was high,
reflecting the fact that the FUT5 Ct value was close to 40,
and hence very variable due to the Poisson distribution of
single target molecules. However, the constancy of the Ct
values independent of cell concentration and the consistent
Ct value difference of 5 (corresponding to a 32-fold dif-
ference in linear terms) between the HSV-1-infected cells
and non-infected cells indicated that the system used for
RNA purification and subsequent RT-qPCR was stable and
sufficient for the conclusions drawn. Altogether, the results
indicated that the 18S rRNA normalisation was reliable and
could also be used in situations where the exact number of
virus-infected cells is not known.
4. Discussion
The present investigation confirms a previous report that
HSV-1 infection induces profound changes in the transcrip-
tion of cellular genes (Taddeo et al., 2002). Transcriptional
up-regulation as well as down-regulation were demon-
strated for four investigated cellular genes, also involving
normally constitutively expressed, so called housekeeping
genes. This poses a major problem for interpretation of
real time PCR-based techniques for determining of tran-
scription rates, since the transcription of such housekeeping
genes have been used for normalisation anticipating that
such genes are transcribed relatively constantly over time.
The results of the present study show the transcription rate
of frequently used housekeeping genes, such as GAPDH
and -actin may vary by orders of magnitude during the
course of HSV-1 infection, thereby introducing intolerable
deviations from correct results.
In general, studies on virus influence on cellular functions
are carried out on infected confluent monolayer cell cultures
under serum-free conditions. An unexpected result, from
the study, was that transcription of GAPDH and -actin
was strongly affected also in non-infected cells under such
conditions. This was in particular true for -actin where a
significant decline in transcription took place already after
3 h of serum depletion in the medium to culminate with a
reduction of transcription by almost two orders of magni-
tude after 24 h (Fig. 4). Therefore, -actin, and for the same
reasons also GAPDH, should be strictly avoided for normal-
isation of TaqMan real time RT-PCR results in human cul-
tured diploid fibroblast irrespective if they are virus-infected
or not. The transcription of 18S rRNA, on the other hand,
remained constant over the period observed with fluctua-
tions practically within the statistical variation of the assay
(cf. Fig. 4), with exception for the 24 h value of non-infected
cells.
When considering the Ct values, which are logarithmic
in nature, it is easy to underestimate the errors introduced
by use of variable RNA references for normalisation. Thus,
the Ct graphs for gB-1 versus GAPDH or -actin may
at a first glance look similar to that of gB-1 versus 18S
rRNA (cf. Fig. 5). However, the transformation of these
data to linear relative concentration values revealed im-
portant differences, suggesting several thousands higher
concentrations of gB-1 RNA in untreated HSV-1-infected
cells compared with acyclovir-treated HSV-1-infected cells
(Fig. 6). It is evident that such values are absurd and incon-
gruous, and totally dependent on the large fluctuations in
transcription of the two reference housekeeping genes dur-
ing virus infection. In contrast, the almost perfect congru-
ency between the linear concentration graph for gB-1/18S
rRNA (Fig. 6, lower panel) and the corresponding con-
centration versus microgram curve of Fig. 2B emphasises
that transcription of 18S rRNA is a stable and endurable
standard for normalisation in determination of the tran-
scriptional activity in virus-infected cells. 18S rRNA was
used for standardisation in transcriptional analysis of host
cell genes in bovine herpes virus-infected MDBK cells
and the results obtained were reasonable in relation to the
changes in gene products observed (Muller-Doblies et al.,
2002).
In the present experimental setup the use of 18S rRNA
for normalisation may appear as unnecessary owing to the
great similarities between the two graphs described above.
However, this reflects the standardised conditions of the
present investigation with identical cell numbers for both
infected and non-infected cells applied for RNA extrac-
tion with no systematic difference between virus-infected
or non-infected cells in the amount of total RNA extracted
(data not shown), explaining the similarity between these
two graphs. However, given other experimental situations
where the actual cell numbers are not known or where only
more heterogeneous cell materials are available there are no
other ways for standardisation than normalisation with a re-
liable housekeeping gene such as 18S rRNA. It must, how-
ever, be pointed out that one important drawback using 18S
rRNA is that this is not a mRNA, which makes this type
of normalisation valid only for total RNA protocols and not
for mRNA protocols. Moreover, the 18S rRNA is usually
expressed at several orders of magnitude higher rates than
most mRNA species which might affect the accuracy of nor-
malisation.
The data showed that the 18S rRNA protocol for normal-
isation was also applicable for analysis of a prototype silent
cellular gene, whose transcription was induced by HSV-1
infection, i.e. FUT5, encoding a fucosyl transferase engaged
in synthesis of complex carbohydrate antigens. The great
enhancement of HSV-1-induced FUT5 transcription by ad-
dition of acyclovir is an effect opposite to that observed
for gB-1 transcription. One probable explanation for this
phenomenon is that the induction of FUT5 transcription is
caused by early  or  HSV-1 proteins, or even earlier by
the mere binding of HSV-1 particles to the cell surface. The
acyclovir-induced enhancement of FUT5 transcription may
then reflect that one or more  proteins could be engaged
in moderation of the FUT5 transcription and that this effect
is abolished owing to the low synthesis rate of gB-1 and
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other  proteins during acyclovir-dependent HSV-1 DNA
replication. Further studies on the mechanisms behind this
finding are underway.
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Cell surface carbohydrate structures including sialyl-Lewis
X (sLex) and Lewis Y (Ley) are important ligands in
normal and malignant tissues. The aim here was to deter-
mine the possible inﬂuence on the expression of such anti-
gens by two viruses varicella-zoster virus (VZV) and
cytomegalovirus (CMV) involved in persistent infections
of humans. We found that infection of human diploid ﬁbro-
blasts with both viruses resulted in transcriptional acti-
vation of several fucosyltransferase (FUT) genes that
were either dormant or expressed at low levels in unin-
fected cells. Both viruses induced FUT3, FUT5, and
FUT6, encoding a1,3- and/or a1,4-speciﬁc fucosyltrans-
ferases. CMV, but not VZV, induced transcription of
FUT1 (encoding an a1,2-speciﬁc fucosyltransferase),
FUT7, and FUT9. The changes in transcription of FUT
genes were expectedly associated with expression of Ley
in CMV-infected cells and sLex in the VZV-infected ﬁbro-
blasts although no expression of these antigens was
observed in uninfected cells. One major explanation for
this difference between CMV- and VZV-infected cells
was that CMV, but not VZV, induced expression of
FUT1, necessary for Ley expression. The induced carbo-
hydrate antigens in CMV- and VZV-infected cells could
be of signiﬁcance for virus spread and possible escape
from immune responses.
Key words: cytomegalovirus/fucosyltransferase/Lewis Y/
sialyl-Lewis X/varicella-zoster virus
Introduction
Several fucosylated histo-blood group antigens, including
sialyl-Lewis X (sLex) and Lewis Y (Ley, Figure 1) are
deeply involved in cancer dissemination and metastasis
(Irimura et al. 1993; Thurin and Kieber-Emmons 2002;
Klinger et al. 2004; Magnani 2004), most likely by decoying
the functions of these structures in normal cells. Thus, sLex or
its sulfated derivatives participate in speciﬁc binding to E-
and P-selectins, thereby promoting activation and homing of
various white blood cells active in innate as well as acquired
immune responses (Muramatsu 2000; Kannagi and Hakomori
2001; Hiraiwa et al. 2003; Uchimura et al. 2005). Ley
is found at the surface of activated granulocytes, possibly
engaged in appropriate adhesion of circulating granulocytes
although this process is less characterized (Dettke et al. 2000).
Owing to biological signiﬁcance of sLex and Ley, the critical
genes for their synthesis are only active on the appropriate
occasions. The changes in expression of carbohydrate antigens
in the tumor cells are in most cases achieved by tumor-
induced changes in the transcription rates of one or more quies-
cent glycosyltransferase (FUT) genes, whose gene products syn-
thesize sLex or Ley (Taniguchi et al. 2000). For human T-cell
leukemia virus type 1 (HTLV-1)-dependent leukemia, induction
of sLex is accomplished by transactivation via HTLV-1 encoded
Tax of the human fucosyltransferase VII (Fuc-T VII) gene
(FUT7) (Kannagi and Hakomori 2001; Hiraiwa et al. 2003).
This ﬁnding raised the question whether viral control of host
cell fucosylation as a pathogenic factor could also be used by
other viruses, where latency and/or persistent infection are
characteristic for the virus–host relationship.
The genetics behind the synthesis of fucosylated carbo-
hydrate antigens is however complex, involving a family of
eight active human fucosyltransferase human genes, desig-
nated FUT1–FUT7 and FUT9, encoding key enzymes in the
formation of sLex and Ley and related histo-blood group anti-
gens of the ABH and the Lewis systems [Reviewed in de Vries
et al. (2001) and Becker and Lowe (2003)]. The eight FUT
genes mentioned belong to two groups with respect to catalytic
activity, where the gene products of FUT1 and FUT2 add
fucose in an a1,2 linkage, whereas the others may add
fucose in an a1,3 and/or a1,4 linkage (de Vries et al.
2001). In spite of these similarities between the members of
each of the two groups, there are important differences
between all enzymes with respect to a number of parameters
including acceptor speciﬁcity and tissue localization (Table I).
There are reasons to believe that also nontransforming
viruses may signiﬁcantly inﬂuence the structures of the carbo-
hydrate antigens of viruses and the infected cell surface by
controlling the regulation of the ﬁne-tuned transcriptional
program of these glycosyltransferase genes (Cebulla et al.
2000; Nystrom et al. 2004). The aim of the present study
was therefore to explore the interactions of varicella-zoster
virus (VZV) and human cytomegalovirus (CMV) with
the host cell glycosylation machinery, focusing on the
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Fax: þ46-31-82 7032; e-mail: sigvard.olofsson@microbio.gu.se
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eight fucosyltransferases (FUT1–FUT7 and FUT9). VZV,
a representative for a-herpesviruses, causes chickenpox, and
thereafter life-long latency in sensory neurons, from which
reactivations may present as herpes zoster or, rarely, as ence-
phalitis. This virus was chosen because of its tight interactions
with T memory cells during viremia (Ku et al. 2005). CMV,
a representative for b-herpesviruses, may cause fevrile
illness including mononucleosis and is thought to remain
life-long in monocytes and lymphocytes. Understanding the
mechanisms of CMV infection has become increasingly
important, because it may cause life-threatening infections in
transplanted and other immunocompromised subjects. CMV
was chosen because of its close interactions with the endo-
thelium and various white blood cells (Mocarski and Tan
Courcelle 2001). As a target cell an embryonic human
diploid ﬁbroblast cell line was chosen, maintained in our lab-
oratory at low passages and characterized in previous studies
(Lundstro¨m et al. 1987; Nystrom et al. 2004), being permissive
for both CMV and VZV. We report that infection with both
CMV and VZV viruses resulted in increased transcription
rates by several orders of magnitudes for at least three of the
FUT genes, but there were also differences between CMV
and VZV, the most important being that only CMV induced
FUT1, encoding a Fuc a1,2-transferase. This resulted in pro-
minent differences between VZV and CMV with respect to
the neo-carbohydrate antigens in the infected cells.
Results
Cell histo-blood group genotyping
As target cells for the present studies, we chose a diploid cell
line of human embryonic ﬁbroblasts (HEL), available at low
passage numbers and equally permissive for both CMV and
VZV. This enabled studies on the inﬂuence of the two
viruses on expression of glycosyltransferase genes in one
and the same cell type. Moreover, as several of the FUT
genes studied are not vital for growth in cell culture, it was
deemed advantageous to avoid transformed, aneuploid cells
with possible asymmetric distribution of the actual FUT
genes among individual cells. The cells were genotyped,
Fig. 1. Structural representation of glycoepitopes.
Table I. Properties of the human fucosyltransferases of the present studya
Gene (GenBank) Fuc-T enzyme speciﬁcity Tissue distributiona Characteristics of HEL cells
Linkage Substrate Genotypeb Possible phenotype
FUT1(H)
(M35531)
Fuc a(1,2) Type 2c Mesenchymal, erythroid NDd H type 2 (Bombay phenotype
extremely rare)
FUT2 (Se)
(U17894)
Fuc a(1,2) Type 1 Epithelial cells (saliva and mucous
membranes)
se428se428 No H type 1, no Leb (Secretor
negative)
FUT3 (Le)
(X53578)
Fuc a(1,3/4) Type 1 and 2; sialylated
Type 1 and 2
Epithelial cells in gastrointestinal
tissue; kidneys
Lele202, 314 Lea, sLea, Lex, sLex (Lewis
positive)
FUT4 (Lex)
(M58596)
Fuc a(1,3) Type 2 Myeloid cells; embryonic;
ubiquitous
NDd Lex, Ley
FUT5
(M81485)
Fuc a(1,3/4) Type 1 and 2; sialylated
type 1 and 2
Low level tissue expression; spleen,
gastrointestinal
NDd Lea, sLea, Lex, sLex, Ley
FUT6
(M98825)
Fuc a(1,3) Type 2 and sialylated
type 2
Gastrointestinal tissue; kidneys; liver,
plasma
FUT6wtFUT6370 Lex, sLex, Ley
FUT7
(X78031)
Fuc a(1,3) Sialylated type 2 Leukocytes; spleen FUT7wtFUT7wt sLex
FUT9
(AJ238701)
Fuc a(1,3) Type 2 Leukocytes; brain; stomach ND Lex, Ley
ABO (J05175) Gal/GalNAc
a(1,3)
H Ubiquitous BOa H and B type 2
aBased on the references: Cameron et al. (1995), Clarke and Watkins (1996), Clarke and Watkins (1997), Kaneko et al. (1999), Natsuka et al. (1994), Sasaki
et al. (1994).
bResults from present study.
cType 1 and 2 imply the Type 1 structure and Type 2 structure, respectively as depicted in Figure 1.
dND, not determined.
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using polymerase chain reaction-sequence speciﬁc primers
(PCR-SSP) and polymerase chain reaction-restriction fragment
length polymorphism (PCR-RFPL) (Larson et al. 1996;
Procter et al. 1997; Elmgren et al. 2000; Bengtson et al.
2001), with respect to those glycosyltransferases previously
shown to be subject to allovariation (de Vries et al. 2001)
and which are synthesized histo-blood group antigens of
relevance for the present study. The results are presented in
Table I. The most important ﬁnding was that the cells were
homozygously defective in FUT2 (stop codon), implying
that they are neither able to express Leb, nor type 1 ABO
antigens, despite the existence of one functional B allele.
Furthermore, the cells contained at least one functional
FUT3, FUT6, and FUT7 allele of each gene.
Time course of CMV and VZV infection and FUT
transcription in virus-infected cells
Replicate cell cultures were infected with CMV or VZV (see
Materials and methods), and virus-infected cells were
extracted for DNA and assayed via real-time PCR for viral
progeny DNA (Figure 2). Typical cytopathic effects (CPE)
were observed for both CMV and VZV at 24 h postinfection
(p.i). Production of progeny VZV DNA was detected at 48 h
p.i. and a plateau phase was reached at 72 h p.i., which is in
accordance with the previously published data (Arvin 2001;
Pass 2001). Production of progeny CMV DNA was detected
at 24 h p.i. and maximal levels were reached at 72 h p.i.
Total RNA from VZV- and CMV-infected cells was
extracted and analyzed by Taqman real-time PCR using the
PCR systems described in Table II. Linear levels of different
FUT transcripts were calculated from DCT values (see
Materials and methods). The arbitrary RNA concentration
values were normalized against 18S RNA enabling direct com-
parisons of differences in the transcript abundances of each
and one of the analyzed FUT genes. The FUT genes studied
could be divided into three different groups with respect to
their transcriptional patterns after infection with CMV or
VZV: (i) FUT genes induced by CMV and VZV (Figure 3),
(ii) FUT genes only induced by CMV (Figure 4), and (iii)
FUT genes whose transcription remained high and relatively
constant in virus-infected cells as well as uninfected cells
during the time interval studied (Figure 5). The transcription
rates in mock-infected cells of the FUT genes of groups
(i) and (ii) were low or undetectable (Figures 3 and 4).
Three FUT genes encoding a1,3/a1,4- (FUT3 and FUT5),
or a1,3- (FUT6) fucosyltransferases belonged to the ﬁrst group
i.e. their transcription rates were strongly induced in VZV- as
well as in CMV-infected cells (Figure 3). The maximal tran-
scription rates of these FUT genes in virus-infected cells
were 100–1600 times higher than the baseline levels obtained
for mock-infected cells.
The second group of FUT genes represents exclusively
CMV-induced genes, containing one a1,2-fucosyltransferase
(FUT1) whose transcription was induced to 20 000 times
over the baseline level by CMV, but not altered by VZV
(Figure 4). The maximal levels during the observation interval
were reached about 70 h p.i.. Also, FUT7 and FUT9 transcrip-
tion was induced at lower levels and different kinetics (FUT7)
in CMV-infected cells, but not altered in VZV-infected cells.
The third group comprised FUT genes that remained rela-
tively unaffected by virus infection compared with the other
two groups (Figure 5). The FUT4 RNA concentration was
high and in the same range (approximately 20 000 arbitrary
units) as the maximal value observed for FUT1 through
CMV induction. In contrast to all other differences between
virus-infected and mock-infected cells, the extraordinary
high value recorded for CMV-infected cells at 24 h p.i. was
not consistently observed from one set of infected cells
to another. The transcription of the inactive (see Table I)
FUT2 gene was relatively constant in the CMV-, VZV-, and
mock-infected cells.
Expression of carbohydrate neo-antigens in
CMV- and VZV- infected cells
Next, we explored whether the induced changes in FUT trans-
formation inﬂuenced the expression pattern of fucosylated
carbohydrate antigens in the virus-infected cells. Conﬂuent
HEL cell cultures were cultured in teﬂon-coated glass wells
where 30–60% of the cells were infected with either CMV
or VZV during conditions in which cell-to-cell spread of
virus was permitted as described in Materials and methods,
Immunoﬂuorescence. The cells were examined in immuno-
ﬂuorescence using antibodies to viral antigens and/or speciﬁc
monoclonal antibodies to deﬁned histo-blood group antigens.
CMV-infected cells were identiﬁed by a typical granular
Fig. 2. Time course of CMV and VZV infections. CMV- and VZV-infected
cells were lysed and DNA was extracted. Viral DNA was analyzed using
real-time PCR.
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Table II. TaqMan real-time PCR primers systems used in the present study
Gene Ass. number (mRNA) Forward primer Reverse primer Probe
FUT1b NM_000148 AGGTATAAACACACCCTCTGTGCTT GAGTTCAGGGACAGACAGTGGTT AAACTGGCAGGTACCGTGCTCATTGC
FUT2b NM_000511 CTCGCTACAGCTCCCTCATCTT CGTGGGAGGTGTCAATGTTCT TGGTCACCAGTAATGGCATGGCCTG
FUT3b NM_000149 GGGATCCCTTTTCGTCACACT CGAACTGGTCTAAGCCTTGCA AGGTGACCTACAGGCTCCGCTCGA
FUT4b NM_002033 AATTGGGCTCCTGCACAC CCAGGTGCTGCGAGTTCT TGGCCCGCTACAAGTTCTACCTGG
FUT5b,c NM_002034 CGCTGGATCTGGTTCAGCAT CAGCCGTAGGGCGTGAG CCCCCAGCAACTCCGGC
FUT6b NM_000150 GCATCCAGACGGGATCCA ACTGCTGCGTCTTGACACCTT CCAGGTCCCCGATCCCTCTAGCAT
FUT7a NM_004479 CCGCTTCTACCTGTCGTTTGA GCGTTGCGCCAGAATTTCT CGCGACTACATTACG
FUT9d NM_006581 CAAGGATTACATCACGGAAAAGC TGGTCCCAGAACAACAGGTACA TACAATGCTTTTCTGGCTGGCT
ST3Gal-IIId NM_006279,NM_174963-72 AGGAAATCGTAAATCATGTGAAGATG TTCCACGCAGAATAATACAAAAATC CAATCTGCTGCTAGCCCTCTGCCTCTTT
ST3Gal-IVd NM_006278 GGGACCAAGGGGAGTGAGG CACCTGAGGCTCTGGATGTTC TCTGCTCCTCCGGGTGCTAGCCA
CMVe AY436380 TGATCACTGTTCTCAGCCACAAT TCCTCTGATTCTCTGGTGTCACC CCCGCGACTATCCCTCTGTCCTCA
VZVe AY013747 TGCAGGGCATGGCTCAGT CCCAAGAACCACATGTCCAAC CGCGGTCCCAAGTCCCTGGA
aMGB (Major Grove Binding Probe), Applied Biosystems.
bThermo Electron, Waltham, MA.
cNystrom et al. (2004).
dEurogentec, Seraing, Belgium.
eMWG-Biotech AG, Ebersberg, Germany.
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intranuclear stain with a CMV-speciﬁc antibody, whereas the
VZV antibody resulted in a cytoplasmic granular staining
(Figure 6). Uninfected cells, used for control purposes,
expressed little if any detectable ﬂuorescence with any of the
antibodies used (K. Nystro¨m unpublished data). In contrast,
30–40% of the CMV-infected cells demonstrated a prominent
cytoplasmic and surface staining for Ley. In addition, 5% of
the cells were positive for sLex, preferentially in the cyto-
plasm, although the intensity of the ﬂuorescence was less pro-
nounced than that observed for the Ley antibody. In contrast,
the VZV-infected cells demonstrated no Ley signal, but a
clear, mainly Golgi-like sLex ﬂuorescence, considerably
Fig. 3. RNA expression of FUT genes induced by both CMV and VZV. Total RNA from VZV- or CMV-infected cells (–†–) and mock-infected cells (–W–) was
analyzed using real-time PCR. FUT gene assignations are indicated in the ﬁgure. The RNA concentrations indicate units are comparable between all graphs in
Figures 3, 4, 5, and 7.
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more intense than in the CMV-infected cells. A weak but yet
consistent surface-associated sLex surface staining, that was
dimmed by the VZV-speciﬁc Tetramethyl Rhodamine Iso-
Thiocyanate (TRITC)-ﬂuorescence in the double-ﬂuorescence
setting, became readily visible in Fluorescein Iso-Thiocyanate
(FITC) single ﬂuorescence (Figure 6, inset in the right
middle panel). About 50% of the VZV-infected cells were
positive for sLex. In some experiments, a weak Lex ﬂuor-
escence was detected in the CMV- or VZV-infected cells,
but this phenomenon was occasional and not reproducible.
No ﬂuorescence was detected with antibodies towards Lea,
Leb, or sLea (K. Nystro¨m, unpublished data).
To further explore the role of sialyltransferase gene
expression, we analyzed the levels of a(2,3)-sialyltransferase
Fig. 4. RNA expression of FUT genes induced by CMV. Total RNA from CMV- and VZV-infected cells (–†–) and mock-infected cells (–W–) was analyzed using
real-time PCR. FUT gene assignations are indicated in the ﬁgure.
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III (ST3Gal-III) and a(2,3)sialyltransferase IV (ST3Gal-IV)
transcription in VZV- and CMV-infected cells (Figure 7).
VZV- as well as CMV-infected cells expressed a high constitu-
tive transcription of these human sialyltransferase genes with
levels of 2000 arbitrary units for ST3Gal-III and 5000 arbitrary
units for ST3Gal-IV using an identical arbitrary unit as in
Figures 3, 4, and 5. This is in line with previous results regarding
the sialylation capacity of the HEL cells (Lundstro¨m et al. 1987).
The relationship among the FUT genes studied and the poss-
ible carbohydrate structures generated by the gene products are
depicted in Figure 8. The presence of Ley in CMV-infected
cells and absence in VZV-infected cells is well in line with
the absence of FUT1 transcription in the infected cells, as for-
mation of H Type 2 is a rate limiting step in Ley synthesis. The
observation that sLex is detectable in VZV- as well as CMV-
infected in the absence of Lex expression is most likely
explained by a high ratio between sialylated Type 2 structure
and Type 2 structure, which is in accordance with the data
above and previous reports regarding expression of highly sia-
lylated glycoproteins in HEL cells (Lundstro¨m et al. 1987).
The absence of detectable sLex in spite of high levels of
FUT4 expression in mock-infected cells may be explained
by a reported restricted capacity of Fuc-T IV to fucosylated
sialylated Type 2 structure (Satoh et al. 2005). The absence
of Lea and sLea is most likely reﬂected low levels of Type 1
structures in the virus- and mock-infected HEL cells.
Discussion
Here, we report that infection of diploid human ﬁbroblasts with
VZV and CMV resulted in expression of novel carbohydrate
epitopes in a manner that is speciﬁc for each of the viruses.
Moreover, we showed that this was correlated with virus-
induced changes in the transcription rates of fucosyltransferases
engaged in the synthesis of histo-blood group antigens
(Figure 8). The particular carbohydrate antigens induced sLex
and Ley are involved in processes by which tumor cells spread
and colonize distal tissues. One intriguing question is whether
this principle is also used by viruses for spread of infected cells.
Regarding the molecular background to the differences in
carbohydrate antigen expression between Ley expressing
CMV-infected cells and sLex expressing VZV-infected cells,
the most prominent factor is the dramatic induction of
FUT1 in CMV-infected cells compared with no induction in
Fig. 5. RNA levels of constitutively expressed FUT genes. Total RNA from CMV- and VZV-infected cells (–†–) and mock-infected cells (–W–) was analyzed
using real-time PCR. FUT gene assignations are indicated in the ﬁgure. The FUT4 assay did not distinguish between RNA encoding the two catalytically active
products of this gene (Taniguchi et al. 2000).
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VZV-infected cells. A fucosyltransferase I(Fuc-T I) enzyme
driven switch from sLex to Ley has been analyzed in other
experimental systems (Mathieu et al. 2004). Thus, transgenic
expression of FUT1 in a number of cell types initiates an efﬁ-
cient formation of the H Type 2 structure that efﬁciently com-
petes with the synthesis of the sialylated Type 2 structure, i.e.
the precursor to sLex (see Figure 8). Accordingly, in CMV-
infected cells, the possibilities for Fuc-T III, IV, V, VII, and
IX to form Lex or sLex must be restricted at high Fuc-T I
activities. On the other hand, in VZV-infected cells, the
absence of Fuc-T I is favorable for sLex synthesis, but not
for Lex synthesis, owing to scarcity of nonsialylated structures
in HEL cells (Lundstro¨m et al. 1987). The potential of the
FUT1 gene product to intercept the sLex synthesis is further
underscored by the fact that this enzyme is localized to the
medial Golgi region in contrast to its competitor for the
Type 2 structure, the trans-Golgi-localized a2,3-sialyltransfer-
ase (Zerfaoui et al. 2002). Our results regarding CMV-infected
cells is somewhat at variance with those published by Cebulla
et al. (2000), reporting induction of sLex and Lex, but not Ley,
in human endothelial cells. The reasons for this discrepancy
could be that other cells were used in that study, no assays
for Ley were reported, and the cells were examined only
after long-term culture.
One interesting feature is that only 30–40% of the
CMV-infected cells expressed Ley and about 50% of the
VZV-infected cells expressed sLex. These seemingly low
ﬁgures probably reﬂected that the cells in the object glass cul-
tures for immunoﬂuorescence were infected at low multiplicity
of infection during longer periods of time to allow cell-to-cell
spread of virus to ensure the existence of cells at different
stages of infection. Carbohydrate signaling is usually transient
in nature (Tsuboi and Fukuda 2001) and this is probably also
true for the present sLex and Ley appearance in the virus-
infected cells. The FUT transcription data depicted in
Figures 3–5 represent the sum of FUT transcription in all
the cells, and it is reasonable that some of the cells are more
active in FUT transcription and others are less active or even
inactive, resulting in the heterogeneous Ley and sLex
expression pattern observed in immunoﬂuorescence. As
expected we found surface-associated sLex in the VZV-
infected cells, but much of the sLex ﬂuorescence was
associated with Golgi-like structures in VZV-infected cells.
This could reﬂect the fact that VZV glycoproteins generally
remain Golgi-associated for a relatively long time resulting
in a comparatively low surface exposition, compared with its
Golgi appearance (Wang et al. 1998).
One key function of sLex is to act as a receptor for primarily
E- and P-selectins during leukocyte trafﬁcking and homing via
the high-endothelial venules (Kannagi 2002; Lowe 2002;
Schottelius et al. 2003). In this context, it is tempting to
compare the early appearance of sLex in VZV-infected cells
with the parallel phenomenon in adult T leukemia cells,
where sLex is strongly upregulated due to transcriptional
induction of the human FUT7 gene by the human T-cell
leukemia virus type 1 (HTLV-1) Tax protein (Hiraiwa et al.
2003). The degree of skin inﬁltration of leukemia in patients
is directly proportional to the fraction of cells displaying
HTLV-1-induced sLex (Kannagi and Hakomori 2001). It is
now established that VZV viremia in primary virus infection
Fig. 6. Immunoﬂuorescence images from CMV- and VZV-infected cells.
Monoclonal human antibodies directed toward CMV or VZV and monoclonal
mouse IgM antibodies against Ley, Lex, and sLex were allowed to bind to the
cells. TRITC-conjugated (red) secondary antibodies were used for the detection
of viral antigens and FITC-conjugated (green) antibodies were used for the
detection of the glycoepitopes. Insert in right middle panel shows the single
FITC ﬂuorescence (double enlargement). The white bar represents 20 mm.
Fig. 7. RNA expression of sialyltransferase genes ST3Gal-III and ST3Gal-IV.
Total RNA from CMV-infected cells (black bar), VZV-infected cells (white
bar), and mock-infected cells (gray bar) was analyzed using real-rime PCR.
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involves T memory cells, infected by VZV in the tonsils for
subsequent cell-bound transport to the skin [Reviewed in
Ku et al. (2005)]. It is easy to imagine that the efﬁciency of
such a viremic colonization should be further potentiated,
given that the virus transiently could induce sLex as a tag for
addressing the appropriate target skin cells. One VZV advan-
tage in expressing sLex on the T memory cells used in
viremia is that sLex does not only permit speciﬁc adhesion
to the target tissue, but also offers the intricate selectin-
mediated mechanism for endothelial passage and tissue extra-
vasation. It should, however, be born in mind that the present
study was performed in HEL cells and further proofs for a
possible VZV use of sLex in viremia must await studies with
VZV-infected T memory cells.
So far, very little is known about the biological functions of
Ley, in spite of the fact that it is expressed very selectively in
biologically active cells. Thus, Ley is expressed during short
intervals in embryogenesis, in activated granulocytes, and in
several types of neoplasia (Dettke et al. 2000; Kannagi
2002), and possible functions suggested include engagement
in the apoptosis process, in activated granulocyte behavior
and not least speciﬁc cellular adhesion (Hiraiwa et al. 2003;
Azuma et al. 2004). Thus, polymorphonuclear leukocytes
play a central role in CMV dissemination and it is therefore
possible that the Ley induction is engaged in speciﬁc adhesion
of infected cells in analogy with previous observations for Ley-
expressing tumor cells (Kannagi and Hakomori 2001; Kim
et al. 2005).
Interference with sLex and Ley expression in tumor cells
including oligosaccharide mimics and humanized anti-
carbohydrate antibodies have been considered for anti-tumor
therapy, and a few of these antibodies have been approved
by Food and Drug Administration for use in humans
[Reviewed by Saleh et al. (2000), Ramsland et al. (2004),
and Brodzik et al. (2006)]. Therefore, should viral expression
of sLex and Ley or related epitopes prove to be of biological
relevance for development of viral disease, as described for
the HTLV-1 induced leukemia, it seems reasonable to
assume that the therapeutical modalities, described above,
could be of interest also for treatment of e.g. CMV or VZV
infections in immunocompromised patients.
Materials and methods
Cells and viruses
HEL cells (Lundstro¨m et al. 1987) that were kept at a low
passage level were used throughout the study. The ﬁbroblasts
were cultivated in Eagle’s MEM with Penicillin,
Streptomycin, and 1% L-glutamine. 10% fetal calf serum
(FCS) was used during cell growth. The CMV laboratory
strain Towne (ATCC-977) was used throughout the study.
The virus titers for Towne were determined by plaque titration
on HEL cells (Lundstro¨m et al. 1987) as previously described
(Chiba et al. 1972). A patient VZV isolate C822 that was typed
by PCR (Bergstrom 1996) was used for the VZV studies.
Viral infection of cells
One plaque forming unit per cell of CMV strain Towne was
added to HEL cells in six-well culture plates (700 000 cells/
well) and one well was used for each infectious sample or
mock-infection. Cell-associated VZV (180 000 particles/cell;
see Real-time PCR), where dimethylsulfoxide was removed
prior to infection, was added to HEL cells at 500 mL/well.
The viruses were allowed to attach to the cells for 3 h at 37 8C
and 5% CO2 before the inoculum was removed. The cells
were washed with phosphate-buffered saline (PBS) and fresh
Eagle MEM with penicillin, streptomycin, and 1% L-glutamine
were added. Virus- and mock-infected cells were harvested by
removing the medium from the well and washing the cells in
PBS. The cells were lysed in 2  Nucleic Acid Puriﬁcation
Lysis Solution (Applied Biosystems, Foster City, CA).
Immunoﬂuorescence
Mock-, CMV-, or VZV-infected HEL cells were trypsinated
and resuspended in Eagle’s MEM, penicillin, streptomycin,
1% L-glutamine, and 10% FCS. Mock-infected and CMV- or
VZV-infected cells (trypsinated at 48 h p.i.) were mixed and
Fig. 8. Hypothetical major pathways for synthesis of fucose-containing
carbohydrates in CMV-infected cells (A) and VZV-infected cells (B). For
structural representations of the different glycoepitopes see Figure 1.
Rectangles with solid lines indicate structures that either detected or are likely
to be detectable according to the experimental data of the present study. Dotted
rectangles represent antigens not detected or not likely detectable in the present
study. Solid arrows represent pathways likely to take place in CMV- or VZV-
infected cells. Open arrows indicate pathways not likely to be utilized in the
virus-infected cells. The B transferase is indicated by a thin arrow.
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added to teﬂon-coated object slides and allowed to further
infect for at least 2 days to ensure infected cells at different
stages. The slides were ﬁxated in cold acetone and stored at
280 8C.
Immunoﬂuorescence was performed on the slides by incu-
bating the cells with human sera containing antibodies directed
against CMV or VZV diluted 1:400 and 1:200, respectively.
Lex, Ley, and sLex were detected using immunoglobulin
(Ig)M antibodies P12, (abcam, Cambridge, UK), F3 (abcam,
Cambridge, UK), and KM93 (Chemicon International,
Temecula, CA), respectively. Possible cross-reactions
between sLea and sLex were ruled out by the use of
MCA2031 (Serotec, Oxford, UK). Lea and Leb were detected
using IgG1 antibodies 7LE and 2-25LE (abcam, Cambridge,
UK). The primary antibodies were incubated for 1 h at
37 8C. TRITC-conjugated anti-human antibody (Jackson
ImmunoResearch, West Grove, PA) and FITC-conjugated
anti-mouse antibody (abcam) were used at dilutions of 1:200
and 1:50 and incubated on the cells for 45 min at 37 8C. The
slides were washed thoroughly in PBS between each of the
antibody incubations. Prolong Antifade Kit (Molecular
Probes, Eugene, OR) was used as a mounting media on the
slides. The slides were analyzed in a Zeiss LSM 510 Meta
confocal microscope using a Plan-Apochromat 36x objective
in oil immersion, and the possibility of cross-reactivity
between TRITC and FITC was checked for in each well.
RNA and DNA extraction
The 6100 Prep Station (Applied Biosystems) was used for the
isolation of RNA (Isolation of Total RNA from Cultured Cells,
Applied Biosystems) and DNA (BloodPrep Chemistry,
Applied Biosystems) from cells and supernatant according to
the manufacturer’s instructions. Brieﬂy, 400 mL of lysed
virus-infected cells or mock-infected cells were added to
96-well RNA or DNA isolations trays used as described by
the manufacturer. Puriﬁed total RNA and DNA were eluded
in a ﬁnal volume of 100 mL. The concentration and purity of
the RNA was checked using spectrophotometry, measuring
the samples at 260 and 280 nm. The 260/280 nm ratio was
2.0+ 0.2.
Real-time PCR
Real-time PCR was performed as previously described
(Nystrom et al. 2004), and the primers and probes are listed
in Table II. Brieﬂy, RNA analysis was carried out using
TaqMan One-Step RT-PCR Mastermix (Applied Biosystems)
and 40 ng of total RNA. A volume of 2 mL of DNA extraction
was added to the real-time PCR to control the infection. The
reverse transcription reaction was performed at 48 8C for
30 min and the following PCR according to the manufacturer’s
instructions, for 40 cycles (95 8C 15 s, 60 8C 60 s) using
2  AmpliTaq Gold DNA Polymerase mix and 40  RT
enzyme mix, forward and reverse primers (0.5 mM and
probe (0.3 mM). The DNA real-time PCR was performed in
the same manner, with omission of the reverse transcription
step and the reverse transcription enzyme mix. All real-time
PCR reactions were performed using 30 mL reaction volumes
and carried out in 96-well plates, which were centrifuged for
1 min at 1000g in a swing-out rotor (Rotina 48R; Hettich,
Tuttlingen, Germany) before the PCR. The ampliﬁcation and
detection was carried out with an ABI prism 7000 sequence
detection system (Applied Biosystems). All RNA samples
were subject to a b-actin PCR without added reverse transcrip-
tase to check for DNA contamination. Samples where DNA
was detected were DNase treated with Turbo DNAfree
(Ambion, Austin, TX) according to the manufacturer’s
instructions.
The CT values were normalized to 18S, which is a housekeep-
ing gene previously shown to be constantly expressed in herpes-
virus-infected cells (Nystrom et al. 2004). Linearized results
were calculated using the DCT method [(Livak and Schmittgen
2001); Applied Biosystem’s User Bulletin #2: Relative
Quantitation of Gene Expression 2001] relative 18S expression
as follows. The linearized DCT expression of a sample
(Arbitrary unit, A) was obtained from the formula:
A ¼ 2(2DCTsampleþDCTreference), where the reference was the one
sample giving the highest FUTDCT value selected among all
the FUT assays depicted in Figures 3, 4, and 5. This enables
direct comparison of the arbitrary unit values given in these
three ﬁgures. As the CT values obtained rather than the linearized
values are normally distributed, it is not possible to use the stan-
dard deviations directly in the graphs. In order to transform the
standard deviation values, derived from CT measurements, to
surrogate error estimates applicable in graphs presenting the
linearized results, the following formula was used for each
value: S ¼ 2(2DCT sampleþDCT referenceþstd 18S þ std sample)2A, where S
represents the length of the error bar, standard deviation values
(std) obtained for 18S PCR and the sample (FUT PCR).
Genotyping
PCR-SSP genotyping of ABO, FUT2, FUT3, and FUT6
mutations. The PCR-SSP assay conditions and the primers
for the ABO mutations, the FUT2 428G . A, 385A . T, and
571C . T, FUT3 59T . G, 202T . C, 314C . T, 508G . A,
1067T.A mutations have been described previously (Procter
et al. 1997; Grahn et al. 2001). The FUT6 PCR-SSP assay was
optimized using DNA samples from individuals with known
FUT6 genotypes (Larson et al. 1996; Elmgren et al. 2000) and
was designed to use the same PCR-program as described in
Real-time PCR. The primers (A. Grahn, unpublished data) were
selected to identify the 370C . T, 730C . G, 738C . T,
739G . A, 907C . G, 945C . A, and 977G.A mutations
and to give products of 819, 462, 455, 453, 282, 245, and
212 bp not interfering in size with each other or with the
human growth factor or developmentally regulated RNA-
binding protein internal controls of 428 and 796 bp, respectively.
All products were analyzed on UltraPURE 1% agarose gel
(Gibco BRL, Paisley, Scotland) in 0.5 mg/mL ethidium
bromide at 125 V and visualized under UV-light.
PCR-RFLP genotyping of FUT7 329G.A mutation. The
genotyping for the FUT7 329G.A mutation was performed
as described in Bengtson et al. (2001) using the primer pair
VII-3s/VII-4as to generate a 1404 bp product further cleaved
by NotI into 791 and 613 bp products.
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Abstract 
We previously showed that herpesviruses varicella-zoster virus (VZV) and cytomegalovirus 
(CMV) infection of diploid human fibroblasts (HEL) resulted in neo-expression of Lewis 
antigens sialyl Lewis x (sLe
x
) and Lewis y (Le
y
), respectively, by transcriptional activation of 
different combinations of normal dormant human fucosyltransferase genes (FUT1, FUT3, 
FUT5, and FUT6), whose gene products are responsible for synthesis of Le antigens.  Here, 
we showed that herpes simplex virus type 1 (HSV-1) induced a similar sLe
x
 expression as 
VZV caused by a similar induction pattern of FUT3, FUT5 and FUT6 transcription in HSV-1 
infected cells. HSV-1 induction of FUT5 was used as a model system for analyzing viral 
activation of dormant fucosyltransferase genes. This was an extremely rapid process, giving 
rise to elevated FUT5 RNA levels at one hour post infection. Using a set of conditional and 
non-conditional HSV-1 mutants, defective in expression of selected viral factors we 
demonstrated that expression of ICP0, an immediate early viral factor, was responsible for the 
HSV-1 effects on FUT5 transcription. In addition, our results suggested that ICP0 RNA rather 
than the translated gene product was directly responsible for FUT5 activation, although the 
known ubiquitinylating activity of the ICP0 protein also seemed to effect transcription of 
FUT5, after the direct activation event of this gene. 
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Introduction 
Several viruses including human 
immunodeficiency virus type 1 (HIV-1), 
human T cell lymphotropic virus type 1  
(HTLV-1), human cytomegalovirus 
(CMV) and varicella-zoster virus (VZV) 
induce formation of carbohydrate 
neoantigens, that are exposed at the 
infected cell surface and sometimes also at 
the viral envelope (1, 4, 15, 16, 25, 26, 
Hansen, 1990 #37). Most of these virus-
induced carbohydrate antigens belong to 
the Lewis families of fucose-containing 
histo-blood group antigens. Thus, HIV-1 
infection may result in neo-expression of 
  
2 
Le
y
 (for structural representations, see Fig 
1) (1), CMV induces expression of sialyl-
Le
x
 (sLe
x
) and Le
y
; (4, 26), and VZV 
induces expression of sLe
x
 (26). The 
HTLV-1 induced sLe
x
 participates in 
lymphoma pathophysiology by catalyzing 
homing of virus-transformed cells to their 
skin localization (17). Besides this, little is 
known so far of the specific functions of 
sLe
x
 and Le
y
 during the viral colonization 
of its host, though homing of virus-infected 
cells to the skin has been shown to play a 
central role in VZV pathogenesis (18). 
 
The important factor behind the CMV- and 
VZV-induced increase in sLe
x
 appears to 
be a prominent induction of transcription 
of at least three fucosyltransferase genes 
that are normally restrictedly expressed in 
many cell types, i.e. FUT3, FUT5 and 
FUT6 (26), where FUT3 and FUT5 
encodes 1,3/4-fucosyltransferases and 
FUT6 encodes an α1,3-fucosyltransferase, 
all of which are involved in the last step in 
synthesis of sLe
x
 (Characterized in (9)). 
Le
y
 is expressed in CMV-infected cells 
because this virus in addition to the VZV-
induced FUT genes mentioned above also 
induces transcription of FUT1 (26), 
encoding an 1,2-fucosyltransferase whose 
catalytic activity is necessary for formation 
of Le
y
, but is incompatible with formation 
of sLe
x
  (7). Hence, sLe
x
 is only expressed 
in a sub-fraction of CMV-infected cells, 
where the Fuc-TI levels are too low to 
permit a complete switch to Le
y
 synthesis, 
resulting in a larger proportion of the 
infected cells expressing Le
y
 and a smaller 
fraction expressing sLe
x
.  
 
In the present paper we have focused on 
the consequences of HSV-1 induced 
changes in the transcriptional rates of 
fucosyltransferase genes mainly for three 
reasons: (i) Expression of fucosylated 
carbohydrates such as Le
x
 are necessary 
for the functional status of CNS regions 
(24), regions of significance for which are 
targets in HSV-1 pathogenesis (28). (ii) 
Owing to its short replication cycle 
compared with CMV and VZV, HSV-1 
provides a more straight-forward and well 
characterized model for exploring the 
molecular mechanism behind the viral 
induction of transcription of selected 
human fucosyltransferase genes. The most 
important findings here were that (i) HSV-
1 induced a similar transcription pattern of 
fucosyltransferase genes as did another α-
herpesvirus, VZV, resulting in sLe
x
 
expression, distinct from that of the β-
herpesvirus CMV, and (ii) ICP0 RNA 
rather than the translated viral gene 
product was responsible for transcriptional 
induction of at least the host FUT5 gene, 
thereby providing an extremely rapid viral 
mechanism for activation of dormant host 
genes in the newly infected cell. 
Materials and methods 
 
Viruses and cells. The wild type HSV-1 
virus Syn17+ and mutant HSV-1 viruses 
dl1403, tsS and tsK  have been previously 
described (3, 6, 21, 31, Davison, 1984 #12, 
Blumel, 1995 #33). The virus titers were 
determined by plaque titration on GMK 
(Green monkey kidney) cells (13) at 37°C 
for Syn17+ and dl1403 whereas 
temperature sensitive mutants were plaque 
titrated at 32°C. Human diploid embryonic 
lung fibroblasts (HEL cells) (20) were used 
throughout the study. The fibroblasts were 
cultivated in Eagle’s MEM with 1% 
penicillin-streptomycin and 1% L-
glutamine. 2% fetal calf serum was used 
during cell growth.  
  
3 
Immunofluorescence. HEL cells were 
trypsinated and resuspended in Eagle’s 
MEM, penicillin, streptomycin, 1% L-
glutamine and 10% FCS. The cells were 
allowed to adhere to teflon-coated object 
slides for 24h. The cells were infected with 
HSV-1 for 4, 6, 9 or 24 hours and 
200µg/ml Cycloheximide (CHX, Sigma 
Aldrich, St. Louis, MO) or 50µM MG-132 
(Merck Bioscience Ltd., Nottingham, UK) 
(5) was added to certain wells. 
Subsequently, the slides were fixated in 
cold acetone and stored at -80°C. 
Immunofluorescence was performed on the 
slides by incubating with human sera 
containing antibodies directed against 
HSV-1 diluted 1:600, and/or IgM 
antibodies against Le
x
, Le
y
 and sLe
x
 (P12, 
(abcam, Cambridge, UK), F3 (abcam, 
Cambridge, UK), and KM93 (Chemicon 
International, Temecula, CA) respectively) 
diluted 1:40. The primary antibodies were 
incubated for overnight at 4ºC. TRITC 
conjugated anti human antibody (Jackson 
ImmunoResearch, West Grove, PA) and 
FITC-conjugated anti mouse antibody 
(Dako, Glostrup, Denmark) were used at 
dilutions of 1:200 and 1:100 and incubated 
1h at 37°C. All dilutions of antibodies 
were performed in 3% BSA in Phosphate 
Buffer Solution (PBS). Prolong Antifade 
Kit (Molecular Probes, Eugene, OR) was 
used as a mounting media on the slides. 
The slides were analyzed in a Zeiss LSM 
510 Meta confocal microscope using a 
Plan-Apochromat 63x objective in oil 
immersion.  
Cell culture experiments. HSV at a 
multiplicity of infection of 8-10 PFU of 
virus/cell were added to HEL cells in 6-
well culture plates (700,000 cells/well). 
Virus was allowed to attach to the cells for 
one hour at 37°C and 5% CO2 before the 
inoculum was removed. After different 
intervals of infection each well was 
harvested and extracted for RNA or DNA 
separately. The cells were then washed in 
PBS and new medium was added. CHX 
(Sigma Aldrich, St. Louis, MO) was added 
at 200µg/ml and 50µM MG-132 (5) to 
certain wells. In experiments involving tsS 
and tsK mutants, cells were incubated at 
32°C, permissive, and 39°C, non-
permissive temperatures, respectively. In 
the experiments with synchronized 
infections, virus was allowed to attach to 
the cells at 4°C and the infection process 
was initiated by transferring the cells to 
37°C. UV inactivated virus for certain 
experiments was created by UV radiation 
of 2250, 4500 or 9000 J, (λmax=252nm), 
respectively. Cells were harvested by 
washing with PBS and lysed with 300 µl 
2x Nucleic Acid Purification Lysis 
Solution (Applied Biosystems, Foster City, 
CA) and PBS, respectively. An experiment 
to control the rate of uptake of dl1403 into 
the infected cell was performed as 
previously described (32). Briefly, cells 
were infected with dl1403 and HSV-1 and 
allowed to attach to cells at 37ºC. The cells 
were subsequently washed 5 times with 
PBS and medium was added and the cells 
were incubated for 1hour and 5 hours. The 
cells were put on ice and washed with PBS 
prior to 1mg/ml proteinase K treatment in 
the presence of fluoride and 30mg BSA. 
The cells were harvested and processed as 
described above. 
RNA and DNA extraction. The 6100 
Nucleic Acid Prepstation,  (Applied 
Biosystems, Foster City, CA) was used for 
purification of total RNA and DNA 
according to manufacturer’s instructions 
including DNase treatment for total RNA 
extraction. 
  
4 
Real time PCR. Real time PCR was 
performed as previously described (26) 
according to manufacturer’s instructions 
regarding Taqman chemistry. Primers and 
probes for FUT1-7 and 9 were previously 
described (26) and primers for HSV-1 
genes are as follows: ICP0 (located in the 
nondeleted section of the ICP0 gene of 
deletion mutant dl1403) forward primer 
TCCGGGTTATGCTAATTGCTTT, ICP0 
reverse primer TTCCCGAAGAAACTCA-
TTACCATA,  ICP0 probe FAMCCCG-
CGGGTCGCTCAATGAATAMRA, ICP4 
forward primer TGTGGATGAGGAACA-
GGAGTTG, ICP4 reverse primer 
GCTGCCACAGGTGAAACCA, ICP4 
probe FAM-TGAGTTGTGTTGTTGGGC-
AGGTGTGGT-TAMRA, gB forward 
primer TTTGTGTACATGTCCCCGTTT-
TAC, gB reverse primer AGAAGCCGT-
CGACCTGCTT, gB probe FAM-ACACC-
GAACACACCAGCTACGCCG-TAMRA 
(Thermo Electron, Ulm Germany) and 
were designed according to the guidelines 
of Applied Biosystems, using Primer 
Express 2.0 (Applied Biosystems, Foster 
City, CA). The CT values were normalized 
to 18S as described previously (26).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
Neo-expression of sLex on HSV-1 infected 
human fibroblasts 
We previously showed that HSV-1 
infection of HEL cells resulted in a 
dramatic increase in transcription of the α-
1,3/4 fucosyltransferase gene designated  
FUT5 (25), whose gene product, Fuc-TV, 
is of relevance for synthesis of sLe
x
 as well 
as Le
y
 (7). First, we investigated whether 
this change was associated with 
neoexpression of any or both of these 
neoantigens. HSV-1 infected and mock-
infected HEL cells were examined in 
immunofluorescence using antibodies to 
viral antigens and/or specific monoclonal 
antibodies to sLe
x
, Le
x
, and Le
y
 (Fig 1). 
HSV-1 positive cells demonstrated a 
predominantly Golgi-like granular staining 
with the sLe
x
 antibody, but no signal was 
detected in uninfected cells demonstrating 
that HSV-1 infection of HEL cells indeed 
resulted in neoexpression of a carbohydrate 
epitope, sLe
x
. We were only able to detect 
little if any expression of Le
x
 or Le
y
 in the 
HEL cells independent of whether they 
were HSV-1 positive or not. In conclusion, 
the expressional pattern of Lewis antigens 
in HSV-1-infected HEL cells therefore 
resembled that of VZV-infected cells, i.e. 
neoexpression of sLe
x
 exclusively, which 
is in contrast to CMV-infected HEL cells 
with a predominant Le
y
 expression (26).  
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Figure 1. Immunofluorescence images from HSV-1 
infected cells. A human IgM-positive serum to 
HSV-1 and monoclonal mouse IgM antibodies to 
Le
y
, Le
x
 and sLe
x
 were allowed to bind to the cells. 
TRITC-conjugated (red) secondary antibodies were 
used for detection of HSV-1 positive cells and 
FITC-conjugated (green) secondary antibodies were 
used for detection of the glycoepitopes. The white 
bar represents 20µ. 
 
Influence of HSV-1 on α-3/4 
fucosyltransferase genes 
Next, we explored possible effects of 
HSV-1 infection on the transcription of 
seven other fucosyltransferase genes than 
the previously investigated FUT5 (25), 
encoding enzymes known to be involved in 
the synthesis either sLe
x
 or related 
fucosylated carbohydrate antigens. A brief 
characterization of these enzymes with 
respect to specificity and tissue expression 
patterns is given in Table 1. HSV-1 
infected and mock-infected cells were 
harvested at different time intervals post 
infection. Total RNA was isolated and real 
time RT-PCR was performed according to 
previously published methods (25). 
Relative concentrations of transcripts from 
different fucosyltransferase genes were 
determined using the ∆CT method, as 
optimized for herpes virus-infected cells 
(26). The transcription rates of four FUT 
genes, i.e. FUT3, FUT5, FUT6, and FUT9, 
were enhanced by HSV-1 infection by at 
least one order of magnitude, (Fig 2). 
Except for FUT9, whose transcription was 
detectable only at 12 h p.i., the maximal 
transcription rates of these genes were 
reached already at 7h p.i., with a decrease 
in the RNA concentrations later in 
infection (Fig 2). The expression of FUT1, 
FUT2, FUT4 and FUT7 was only 
marginally changed after HSV-1 infection 
compared with expression of FUT3, FUT5, 
FUT6, and FUT9 (data not shown). These 
observations were in accordance with the 
previously published FUT expression 
pattern induced by VZV, but differing 
from that of CMV regarding the ability of 
the latter to induce transcription of FUT1, 
compatible with Le
y
 expression (26). 
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Table 1. Properties of the human fucosyltransferases 
 
Gene 
(GenBank) 
 
Enzyme 
abbreviation
/Linkage
a
 
 
 
Synthesized Type 1 
Structures
a 
 
Synthesized Type 2 Structures
a 
 
FUT1 (H) 
(M35531) 
Fuc-TI 
Fuc (1,2) 
  
 
H Type 2
c 
FUT2 (Se) 
(U17894) 
Fuc-TII 
Fuc (1,2) 
  
H Type 1
c
 
 
FUT3 (Le) 
(X53578) 
Fuc-TIII 
Fuc (1,3/4)   Lea 
Le
b
 
 
sLe
a
 
 
 
 
 Le
x
 
Le
y
 
 
sLe
x
 
 
 
 
FUT4 (Le
x
) 
(M58596) 
Fuc-TIV 
Fuc (1,3) 
 
Le
x
,  
 
Le
y
 
FUT5 
(M81485) 
Fuc-TV 
Fuc (1,3/4) Le
a
 
Le
b
 
sLe
a
 
Le
x  
Le
y 
 sLe
x 
FUT6 
(M98825) 
Fuc-TVI 
Fuc (1,3) 
 
 Le
x
, 
Le
y
 
sLe
x
 
FUT7 
(X78031) 
Fuc-TVII 
Fuc (1,3) 
  
 
sLe
x
           
FUT9 
(AJ238701) 
Fuc-TIX 
Fuc (1,3) 
 
Le
x
,   Le
y
 
a 
Based on the reference: (7) 
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Figure 2.  RNA expression of FUT genes induced by HSV-1 ( ) compared to mock-infected 
HEL cells ( ). The arbitrary unit for RNA concentration is identical for all four panels. 
 
Viral gene transcription essential for 
FUT5 induction 
The next series of experiments were 
designed to identify the viral factor(s) 
responsible for virus induced induction of 
FUT genes. We chose FUT5 as a model 
gene for these studies because the 
transcription kinetics of this gene in HSV-
1 infected cells was characterized in detail 
previously (25). As transcriptional 
induction of FUT5 obviously was an early 
event, we first determined whether the 
mere binding of virions to the cells, and/or 
newly delivered virion proteins (e.g. 
tegument protein VP16, VHS) alone were 
sufficient for this process, owing to their 
significance for early transcriptional 
activation of viral and cellular genes 
(reviewed in (33)). Thus, HEL cells were 
incubated with HSV-1 particles, whose 
DNA was inactivated with different doses 
of UV radiation (2) (Fig 3). UV radiation 
of HSV-1 efficiently destroyed the viral 
ability to induce FUT5 transcription in the 
infected cells as recorded at 5 and 8 hours 
post infection, respectively. The finding 
that borderline doses of UV radiation 
(2250 J) suppressed early induction of 
FUT5 transcription to baseline levels 
emphasized the necessity of expression of 
intact HSV-1 genes for FUT5 activation. 
The slight, but reproducible increase in the 
late FUT5 transcription at 24h p.i. (second 
run of viral multiplication) confirmed that 
the virus suspension indeed was treated 
with a borderline UV dose, not sufficient 
for inactivation of all viral genomes in the 
virus suspension. Altogether these results 
indicated that the mere presence of virion 
proteins in the infected cell, including 
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VP16 or other structural components 
known to influence the transcriptional 
activity, was not sufficient to enhance 
transcription of FUT5 in the absence of a 
functional genome.  
  
Figure 3. Effect of UV-radiation of HSV-1 on 
expression of FUT5 in virus-infected cells 
harvested at the times indicated p.i. Virus was 
exposed to UV-radiation for the time periods 
indicated. Total RNA was isolated and FUT5 RNA 
levels were detected by Real-time PCR. 
Immediate early gene ICP0 essential for 
FUT5 induction  
Next, we determined whether HSV-1 
induction of FUT5 transcription was 
controlled by immediate early protein 
ICP0. This protein is the first to be 
transcribed during lytic HSV-1 infection 
and plays a key role in the interactions 
with the host cell (10, 14). The studies 
were carried out with a deletion mutant 
HSV-1 mutant virus dl1403 containing 
deleted segments in both copies of ICP0 
(31). HEL cells were infected with 10 
PFU/cell of wild type virus and a 
corresponding amount of virus particles of 
the ICP0 deletion mutant, respectively. 
Total RNA was isolated from lysed cells at 
different time intervals, and the material 
was assayed using real time RT-PCR for 
FUT5, the transcribed part of the ICP0 
gene and as a further control also the ICP4 
gene (Fig 4), the latter encoding another 
immediate early (IE) protein. No early 
onset of FUT5 transcription was detected 
in dl1403-infected cells, whereas the wild 
type virus infection resulted in 
significantly increased levels of FUT5 
RNA as early as 5h p.i. As expected, no 
detectable amounts of ICP4 or ICP0 RNA 
were found in the dl1403-infected cells. 
We controlled that these differences 
between mutant dl1403 and wild type virus 
did not reflect an unspecific defectiveness 
of dl1403 virus particles to perform early 
virus-cell interactions including attachment 
and entry, using proteinase K sensitivity of 
attached extracellular virus (32) (Fig 5). 
Thus, equal amounts of physical virus 
particles of dl1403 and wild type virus, 
respectively, were added to HEL cell and 
similar amounts of proteinase K-resistant 
intracellular viral DNA were detected at 1h 
p.i. for both dl1403 and wild type virus. 
The late increase of intracellular wild type 
but not dl1403 DNA at 5h p.i. was 
expected, owing to inefficient early HSV-1 
DNA replication in the absence of 
functioning ICP0 (10, 29). Altogether these 
results indicated that induction of FUT5 in 
HSV-infected cells is dependent on a 
functional ICP0 gene.  
Immediate early gene ICP4 not essential 
for FUT5 induction 
The possible significance of ICP4 in the 
induction of FUT5 was investigated, 
seeing as this protein together with ICP0 
plays a central role for regulation of early 
HSV-1 transcription (10, 29). We used two 
temperature sensitive mutant for these 
studies: tsK, conditionally defective in 
ICP4 (6), and tsS, defective in the origin-
binding protein, the latter to control for 
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non-permissive conditions (3) (Fig 6). This 
control was possible because HSV-1 
induced FUT5 transcription is super-
induced by inhibition of viral DNA 
synthesis (25), and a conditional mutant in 
the ori-binding protein should therefore be 
expected to constitute a super-inductor of 
  
Figure 4. Expression of ICP4, ICP0, and FUT5 in 
mock-infected cells ( ) and cells infected with 
dl1403 ( ) or wild type virus ( ). The ICP0 PCR 
system was designed to detect the non-deleted 
portion of ICP0 in the dl1403 genome. 
FUT5 at non-permissive temperature. In 
accordance, tsS infected cells expressed 
five times higher levels of FUT5 RNA than 
did wild type virus-infected cells at 39°C, 
confirming non-permissive conditions. In 
contrast, both tsK and wild type virus 
infected cells were equally efficient 
producers of FUT5 RNA at non-permissive 
temperature, approximately 100 times than 
did the uninfected cells. At permissive 
temperature (32°C), no differences in 
FUT5 RNA levels could be detected 
between HSV-1, tsS and tsK-infected cells. 
The somewhat high level of FUT5 RNA in 
uninfected cells most likely reflected sub-
thermal stress. Altogether, no role of ICP4 
could be identified in HSV-1 induction of 
FUT5 transcription. 
 
 
Figure 5. Accumulation of Proteinas K-resistant 
dl1403 and wild type virus in infected HEL cells. 
Cells were treated with Porteinase K at 1h and 5h 
p.i., respectively to remove attached but not 
engulfed virus. Viral DNA copies were assayed 
using Real-time PCR. 
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Figure 6. FUT5 RNA expression in HEL cells 
infected with HSV-1, ori binding protein mutant tsS 
and ICP4 temperature sensitive mutant tsK. FUT5 
RNA was assayed at permissive (32ºC) and non-
permissive (39ºC) temperature. 
 
ICP0 gene products and FUT5 induction 
Besides regulation of viral gene 
transcription, the ICP0 gene is involved in 
modulation of host cell activities by at least 
two mechanisms: (i) the ICP0 RNA in 
absence of the translated gene product is 
the ICP0 protein exerts a ubiquitinylating 
activity that interferes with the function of 
ND10 (PML, POD), a nuclear storage 
compartment for cellular transcription 
factors (8). The next series of experiments 
was to determine if any or both of these 
mechanisms were involved in induction of 
FUT5 transcription. First we investigated 
the early transcription kinetics of ICP0 and 
FUT5 was studied in synchronously 
infected cells at a high multiplicity to 
determine whether appearance of FUT5 
and ICP0 RNA coincided. Under these 
conditions no ICP0 RNA was detected and 
only a background level of FUT5 RNA 
was detected at 30 minutes p.i. (Fig 7). At 
1h substantial amounts of ICP0 RNA was 
detected accompanied by an about fivefold 
increase in the amount of FUT5 RNA, 
indicating a similar early transcription 
kinetics of both genes. However, newly 
translated ICP0 protein is detectable only 
at 2 h at the earliest, even in cells infected 
at a high multiplicity of infection of HSV-1 
(Reviewed in (28)), favoring the notion 
that ICP0 RNA rather than the translated 
gene product is responsible for HSV-1 
induced transcriptional activation of FUT5 
 
  
Figure 7. FUT5 RNA expression in synchronized 
HSV-1 infected ( ) and uninfected ( ) HEL cells 
30, 60 and 90 minutes, respectively, post viral 
binding. 
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Figure 8. Distribution of ICP0 in HSV-infected and mock-infected HEL cells or infected and uninfected cells 
treated with CHX and/or MG-132. Cells on Teflon-coated cultures were fixed and processed for 
immunofluorescence at 4h, 6h, and 9h p.i., respectively. ICP0 was detected by indirect immunofluorescence 
using a mouse monoclonal antibody to ICP0 and a FITC-conjugated second antibody. The white bar represents 
20µm. 
 
 
Next we intended to confirm the role of 
ICP0 RNA using CHX for inhibition of 
viral gene translation. In addition MG-132 
was used to inhibit the possible role of 
ND10 involvement in FUT5 induction. 
The effect on ICP0 appearance of these 
two inhibitors was assayed at different 
time points, using indirect immune-
fluorescence with ICP0-specific 
monoclonal antibodies (Fig 8). In 
untreated, HSV-1 infected cells the ICP0 
staining was associated with nuclear 
granulae resembling ND-10, known to be 
involved in early transcription of DNA 
viruses (22). These structures were 
observed at 4h and 6h p.i., though at 9h 
p.i., the ICP0 stain was localized in the 
cytoplasm, which is in accordance with 
previous reports (14, 19). In contrast, no 
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ICP0 staining was found in the HSV-1 
infected cells treated with CHX, 
confirming that translation of the ICP0 
RNA indeed was inhibited. We found that 
MG-132 treatment had dramatic effects on 
the distribution of ICP0 in HSV-1-infected 
cells, especially from 6h p.i. and onwards. 
Thus at 4 h p.i. ICP0 in MG-132 treated 
cells appeared as nuclear granulae with the 
same morphology and the same intensity 
as described for the untreated HSV-1-
infected cells. However, whereas the 
number of fluorescent granulae tended to 
decrease in the untreated cells we observed 
a prominent increase of such intranuclear 
structures in the presence of MG-132 at 6h 
p.i. This difference was even more obvious 
at 9 h p.i. where the ICP0 stain still was 
associated with nuclear granulae in the 
MG-132 treated cells whereas the ICP0 
stain at 9 h p.i. was totally cytoplasmatic. 
This difference in ICP0 behavior between 
MG-132 treated and untreated HSV-1-
infected cells at 6 and 9 h p.i., respectively, 
is in line with results reviewed by (14),(19) 
indicating that MG-132 induced inhibition 
of the ubiquitinylating activity of ICP0 
results in ICP0 accumulation in ND10 like 
structures and subsequent impairment of 
ND10 function.   
 
The effect of CHX and MG-132 on FUT5 
induction was explored in RNA from 
HSV-infected cells harvested at 2.5 and 9h 
p.i., respectively (Fig 9). The main result 
from the 9h p.i. experiments was that 
HSV-1 induced a prominent transcription 
of FUT5 also in the presence of CHX (Fig 
9, upper panel). The higher transcription 
rate of FUT5 in CHX treated, HSV-1-
infected cells compared with untreated, 
HSV-1-infected cells reflected a general 
higher FUT5 transcription background in 
the presence of CHX. This is underscored 
by a corresponding difference in FUT5 
transcription between CHX treated and 
untreated uninfected cells. In contrast, 
MG-132 abolished the ICP0 induced FUT5 
induction at 9h p.i. (Fig 9, upper panel). 
This was not expected from the results 
above that ICP0 in the absence of ICP0 
protein is responsible for FUT5 induction. 
However, the results that MG-132 
treatment resulted in an abnormal, 
prolonged accumulation of ICP0 protein in 
ND10-like structures could reflect 
malfunctioning ND10 like structures 
incompatible with normally functioning 
host cell transcription later than 6h p.i. 
(See Fig 8). To explore this possibility, we 
investigated the effect of MG-132 and 
CHX at 2.5h p.i., i.e. before abnormal 
accumulation of ICP0 protein in the ND10 
structures (Fig 9, lower panel). As 
expected, we found a prominent induction 
of FUT5 in the presence of CHX and a 
modest HSV-1 induction of FUT5 in the 
absence of MG-132 and CHX. However, 
MG-132 as well as a combination of CHX 
and MG-132 resulted in an inhibition of 
FUT5 transcription. These results 
demonstrated that presence of ICP0 RNA 
as well as proteasome function is necessary 
for early induction of FUT5 transcription 
in HSV-infected cells.  
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                 Figure 9. FUT5 RNA expression in HSV-1 infected and mock-infected HEL cells 
         treated with cycloheximide and/or MG-132. 
Discussion 
 
The selectin ligand s-Le
x
 is induced by a 
few representatives of herpesvirideae and 
retroviruses including VZV, HSV-1, 
HTLV-1, and during certain circumstances 
also CMV. In line with the natural function 
of sLe
x
 as a selectin ligand that participates 
in e.g. leukocyte homing there is some 
evidence that sLe
x
 also participates in viral 
host colonisation at least with regards to 
HTLV-1 and CMV (4, 17). The 
mechanism by which HTLV-1 induces 
sLe
x
 is known in detail: The viral gene 
product Tax activates a dormant host gene, 
FUT7, which encodes a fucosyltransferase 
of relevance for the critical steps in sLe
x
 
synthesis. We explored the process by 
which a representative for herpesviruses,  
 
 
 
 
HSV-1, induced neoexpression of sLe
x
, 
and here, we show that this represent a 
viral strategy for controlling host gene 
expression both with respect to the cellular 
genes involved and the viral mechanism 
for activation. Thus, herpesviruses 
including CMV, VZV (26) and HSV-1 
(present data) induce expression of sLe
x
 by 
one or more of the fucosyltransferases 
(Fuc-TIII, Fuc-TV, and Fuc-TVI) encoded 
by FUT3, FUT5, or FUT6, respectively, 
whereas HTLV-1 activates solely FUT7, 
whose gene product Fuc-TVII in fact is an 
activation marker of several types T cells, 
being the target for HTLV-1. 
 
Fuc-TVII differs from the fucosyl-
transferases encoded by FUT3, FUT5, and 
FUT6 in the sense that the Fuc-TVII only 
is able to fucosylate the sialylated 
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precursor (See Table 1) whereas the other 
fucosyltransferases mentioned have the 
capacity to fucosylate a wider variety of 
precursors. In other words, Fuc-TVII is 
tailor-made to form sLe
x
 even if the cell 
should contain immediate precursors to 
e.g. Le
x
 or Le
y
. This means that the FUT1 
dependent expression of Le
y
 in CMV-
infected cells should not have been 
possible, should herpesviruses induce a 
Fuc-TVII in place of Fuc-TIII, Fuc-TV, 
and Fuc-TVI.  
 
The exploration of the nature viral factors 
responsible for HSV-1 induced 
transcription of host fucosyltransferase 
genes was carried out using FUT5 and a 
model gene. From these studies it was 
clear that the most important difference as 
to viral factors engaged in induction of 
sLe
x
 between HTLV-1 and HSV-1 is that 
the former utilises a classical retroviral 
transactivator protein, Tax, which induces 
transcription via a CRE sequence in the 
human FUT7 promoter. This is in contrast 
to somewhat surprising mechanism used 
by HSV-1 for activation of FUT5 
demonstrated here, requiring specific viral 
RNA and thus active also in the absence of 
viral protein synthesis. The inhibitory 
effect of proteasome inhibition of FUT5 
transcription is probably not an effect of 
ICP0 function, because it takes place also 
in the presence of CHX at both time points 
studied. Thus, the most probable 
explanation for the inhibition is an MG-
132 effect on RNA polymerase II 
transcription (11, 27). The conclusion that 
ICP0 RNA is a key actor was based on the 
finding that FUT5 transcription was 
induced during cycloheximide treatment of 
infected cells and by the fact that FUT5 
transcription was an immediate early 
process with a kinetics congruent with 
ICP0 transcription. It could be argued that 
ICP0 is an inducer of other early viral 
factors and that our finding only reflected 
an indirect role of ICP0 paving the way for 
synthesis of other viral factors being the 
real inducers of FUT5. However, the 
cycloheximide resistance of FUT5 
induction indicated that this is not a likely 
scenario as it implies that ICP0 RNA is 
able to induce transcription of other viral 
genes, whose RNA should be able to FUT5 
induction in the  absence of protein 
synthesis.  The notion that ICP0 RNA 
rather than the translated gene product is 
responsible for inducing cellular activities 
is not new.  Thus, ICP0 RNA alone may 
induce apoptosis in HSV-1-infected cells 
(30), a process later reversed via 
expression of several different HSV-1 
proteins (Reviewed by (12, 23)). The 
present study is, however, the first 
demonstration of a viral RNA, acting as a 
specific inducer of a dormant host 
glycosyltransferase gene. 
 
The HSV-1 strategy to use a viral RNA, 
and in particular an RNA encoded by an IE 
gene, for the initial step of FUT5 induction 
offers advantages for the virus compared 
with the Tax-dependent HTLV-1 induced 
activation of FUT7. Firstly, this is a 
prerequisite for a very rapid activation of 
the host FUT5 gene as the concept of an 
RNA inducer eliminates delays caused by 
RNA transport to the cytoplasm, 
translation, and transport of the transported 
protein to the nucleus, inevitable and time-
consuming processes associated with 
immediate early viral proteins as inducers 
of intranuclear activities. Moreover, the 
RNA concept also permits that at least the 
first steps of the virus-induced activation 
of FUT5 takes place without any 
presentation of viral B and T cell epitopes 
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in the newly infected cells. This latter 
aspect may be of relevance for the latent or 
persistent state of HSV-1 in the infected 
neuron, where it at least theoretically 
should be possible for the viral genome to 
influence the cell surface glycotopes of the 
latently infected neuron by a short pulse of 
ICP0 transcription in the absence of any 
expression of viral proteins. This 
possibility is intriguing in view of the 
multitude of surface glycotopes of 
relevance for the functional status of neural 
cells (34). 
 
It is important to emphasize that the ICP0-
dependent activation of host 
fucosyltransferase genes, here exemplified 
by FUT5, represents only one of several 
steps in the virus-induced regulation of 
sLe
x
 expression over time. Thus, inhibition 
of viral DNA synthesis is associated with 
hyperexpression of FUT5 RNA, 
compatible with the notion that viral late 
proteins also are engaged in regulation of 
FUT5 transcription (25). It is therefore 
reasonable assume that virus-induced 
regulation of sLe
x
 expression over time 
involving several points for viral control of 
which the ICP0 RNA-dependent FUT5 
activation represents the first one. At 
present no specific role for the HSV-1 
induced sLe
x
 can be assigned in analogy 
with the defined role for skin colonisation 
of HTLV-1 leukemia cells (17) or for 
endothelial adhesion of infected cells as 
suggested for CMV (4). Although its 
biological relevance still remains 
enigmatic a possible function of HSV-1 
induced expression of sLe
x
 or similar 
glycotopes may be found in interactions 
between HSV-1 and its many target cells, 
including epithelial cells, leukocytes, and 
neuronal tissue. 
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Abbreviations 
 
CHX – cycloheximide 
CMV - cytomegalovirus 
dl1403 – HSV-1 ICP0 deletion mutant 
FITC – Fluorescein Iso-Thiocyanate 
FUT – fucosyltransferase gene 
HEL – human embryonic lung fibroblast 
HSV-1 – herpes simplex virus type 1 
HTLV-1 - human T cell lymphotropic 
virus type 1 
ICP0 – infected cell protein 0 
ICP4 – infected cell protein 4 
IE – immediate early 
Le
a
 – Lewis a 
Le
b
 – Lewis b 
Le
x – Lewis x 
Le
y
 – Lewis y 
p. i. – post infection 
sLe
a
 – sialyl Lewis a 
sLe
x
 – sialyl Lewis x 
PBS – Phosphate Buffer Solution 
tsK – temperature sensitive mutant in ICP4 
tsS – temperature sensitive mutant in ori 
binding protein 
TRITC – Tetramethyl Rhodamine Iso-
Thiocyanate 
VZV – varicella-zoster virus 
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